Introduction {#s1}
============

Rapid modulation of gene expression is critical for cells to respond to environmental challenges and to initiate developmental programs. Eukaryotic cells have developed a variety of mechanisms to achieve tight regulation of gene expression. This includes post-transcriptional control of messenger RNA (mRNA) levels by the regulation of translation or by varying the rates of mRNA degradation. Many of these post-transcriptional regulatory mechanisms, including the transition from mRNA translation to storage or decay, are not well characterized.

Cytoplasmic mRNAs are marked by a 7-methylguanosine cap at the 5' end and by a polyA tail at the 3' end. These modifications enable interaction with translation factors, including the cap-binding complex (eIF4F) and the polyA binding protein (Pab1) and protect the mRNA against degradation ([@bib13]). Given their impact on both translation and mRNA decay, the status of the 5' and 3' ends of the mRNA, as well as the complement of proteins that bind the mRNA termini, are tightly controlled. In budding yeast, a key event for the entry of mRNAs into the degradation pathway is the removal of the polyA tail ([@bib49]), which is predominantly accomplished by the CCR4-NOT complex ([@bib76]). While deadenylated mRNAs can also be degraded from the 3' end by the 10-subunit exosome complex ([@bib12]), mRNA decay in *S. cerevisiae* occurs predominantly via removal of the 5' cap by the Dcp1-Dcp2 decapping enzyme, followed by degradation by the 5'-3' exonuclease, Xrn1 ([@bib27]; [@bib66]).

Under certain stress conditions, such as glucose starvation or osmotic shock, protein factors involved in mRNA turnover can assemble into larger mRNP foci, known as processing bodies (PBs)([@bib64]; [@bib69]). PBs are dynamic, membrane-less structures that appear to form from multivalent interactions between proteins and RNA in a liquid-liquid phase separation phenomenon ([@bib18]; [@bib24], [@bib23]; [@bib29]). Remarkably, PBs and several other related types of mRNP granules, including stress granules, germ granules, and neuronal transport granules, form in a number of different species and cell types, and in a variety of different biological contexts, suggesting these structures are important for cellular function ([@bib20]; [@bib39]; [@bib73]). There is increasing evidence that the ability to form PBs is critical for survival under various stress conditions. For example, cells unable to form PBs show a severe loss in viability in stationary phase ([@bib58]; [@bib62]). Furthermore, ectopic expression of highly expressed mRNAs in cells that cannot form PBs is toxic ([@bib43]). Because of their composition, PBs are postulated to be sites of mRNA storage and/or mRNA degradation ([@bib2]; [@bib3]; [@bib17]). Yet, how the cell regulates PB assembly and disassembly, and how PBs modulate gene expression, has remained elusive.

It is likely that PB formation requires factors that can either remodel the translating mRNP complex or stimulate the formation of a decay-competent or repressed mRNP. The DEAD-box ATPase Dhh1 stimulates mRNA decay and translation repression ([@bib9]; [@bib14]; [@bib22]; [@bib67]) and is thought to function at an early step in PB formation ([@bib68]), making it a good candidate to facilitate mRNA inactivation. Similar to other DEAD-box proteins, Dhh1 possesses N- and C-terminal RecA-like domains connected by a short linker, and can bind RNA with high affinity in a sequence-independent manner through the phosphate backbone ([@bib11]; [@bib44]; [@bib60]). *In vitro*, Dhh1 has a significantly lower ATPase activity than other well characterized DEAD-box proteins such as eIF4A or Ded1 ([@bib16]; [@bib19]; [@bib56]; [@bib70]). This is likely due to intramolecular interactions between its N- and C-terminal RecA lobes that hold Dhh1 in a conformation that is not competent for ATP hydrolysis ([@bib11]; [@bib63]) suggesting the ATPase activity of Dhh1 is stimulated by factors that can alter the conformation of its two RecA domains.

Several recent studies have revealed that DEAD-box proteins can be stimulated or inhibited by *trans*-acting factors. These interacting partners appear to share a common 3D architecture, namely, the presence of a MIF4G fold -- a highly alpha helical HEAT repeat-like structure found in a number of different DEAD-box-interacting proteins, including eIF4G (with eIF4A), Gle1 (with Dbp5) and CWC22 (with eIF4AIII in higher eukaryotes) ([@bib7]; [@bib48]; [@bib53]; [@bib61]). Intriguingly, DDX6, the mammalian homolog of Dhh1, binds directly to CNOT1 (Not1 in *S.c*.), the central scaffold subunit of the CCR4-NOT deadenylase complex, through its MIF4G domain ([@bib10]; [@bib47]) and CNOT1 binding activates the ATPase of DDX6 ([@bib47]). The binding surface between these two proteins is conserved between yeast and human ([@bib59]) suggesting that the interaction between Not1 and Dhh1 is also important for modulating the activity of Dhh1 in budding yeast.

In this study, we examine the ATPase activity of Dhh1 *in vitro* and *in vivo*, and demonstrate that the ATPase cycle of Dhh1 is a critical regulator of PB nucleation and disassembly. Cells expressing a Dhh1 variant carrying a mutation in the DEAD motif (E195Q, or Dhh1^DQAD^) that disrupts ATP hydrolysis form constitutive granules with both the behavior and composition of PBs induced during glucose starvation. Using recombinant proteins, we show that Not1 stimulates the ATPase activity of yeast Dhh1, similar to its function in mammals. Disruption of the interaction between Dhh1 and Not1 *in vivo* leads to the formation of PBs in the absence of stress, similar to the catalytically dead Dhh1^DQAD^ allele. Furthermore, we demonstrate that Dhh1, ATP, and RNA, are sufficient to form liquid droplets *in vitro* with the dynamic behavior of PBs, and that these droplets can be dissolved by addition of purified Not1. Overall, these results reveal that the ATPase activity of Dhh1 is a critical regulator of PB dynamics.

Results {#s2}
=======

Disruption of the ATPase activity of Dhh1 triggers formation of *bona fide* processing bodies {#s2-1}
---------------------------------------------------------------------------------------------

Previously, our lab demonstrated that abrogation of the ATPase activity of Dhh1 through mutation of the conserved DEAD motif (Dhh1^E195Q^, henceforth Dhh1^DQAD^; see [Supplementary file 2C](#SD2-data){ref-type="supplementary-material"} for a list of all Dhh1 mutants in this study) mislocalizes Dhh1 to large Dcp2-positive foci in the absence of stress ([@bib9]). To differentiate whether loss of Dhh1 ATPase activity triggers formation of genuine processing bodies or whether these Dhh1^DQAD^-induced foci are anomalous granules, we monitored the localization of several PB components -- namely Dcp1, Edc3, and Xrn1 -- in both *DHH1* and *dhh1^DQAD^*mutant cells. Similar to the PB composition in glucose starvation conditions, all three GFP-tagged proteins colocalized with Dcp2-mCherry in Dhh1^DQAD^-expressing cells in glucose-rich conditions ([Figure 1A](#fig1){ref-type="fig"}). In contrast, the stress granule marker Pab1 did not assemble into foci in *dhh1^DQAD^* cells ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) demonstrating that Dhh1^DQAD^ granules are composed of proteins found in *bona fide* PBs.10.7554/eLife.18746.003Figure 1.Loss of the ATPase activity of Dhh1 triggers *bona fide* processing body (PB) formation.(**A**) Known PB components localize to Dhh1^DQAD^ foci. Cells co-expressing the indicated PB component were grown to exponential growth phase, then shifted to glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Scale bar: 5 μm (**B**) Constitutive PB formation by Dhh1^DQAD^ is rescued by the presence of wild-type Dhh1. Dhh1-GFP or Dhh1^DQAD^-GFP was expressed from a *CEN* plasmid in *DHH1* or *dhh1∆* cells and were treated as in (A). Scale bar: 5 μm (**C**) Loss of ATPase activity mildly disrupts degradation of a Dhh1-tethered mRNA. Dhh1 or Dhh1^DQAD^ was co-expressed as a PP7CP fusion protein in *dhh1∆* cells expressing *FBA1-PP7L. FBA1* mRNA levels were measured by qPCR and normalized to *ACT1* mRNA. Graphs show mean mRNA levels from three independent experiments of biological triplicate samples. Error bars represent SD. A student's t-test comparing Dhh1 and Dhh1^DQAD^ is shown. Asterisks indicate p\<0.005. (**D**) *FBA1* mRNAs do not colocalize with PBs in Dhh1 or Dhh1^DQAD^-expressing cells, suggesting functional mRNA decay, but enrich in PBs in *xrn1∆* cells. The indicated strains were grown to exponential growth phase, shifted to either glucose-rich (2% glucose) or glucose starvation conditions for 20 min, fixed with paraformaldehyde and processed for smFISH. Depicted is a maximum projection of the central 10 planes of a 3D image. Insets show representative cells (1.67X magnification). The graph shows the quantification of a representative experiment (n = 2 biological replicates). Scale bar: 5 µm. (**E**) *GFA1* mRNAs do not colocalize with PBs in Dhh1 or Dhh1^DQAD^-expressing cells, suggesting functional mRNA decay, but enrich in PBs in *xrn1∆* cells. The indicated strains were grown to exponential growth phase, shifted to either glucose-rich (2% glucose) or glucose starvation conditions for 20 min, fixed with paraformaldehyde and processed for smFISH as in (**D**). Insets show representative cells (1.67X magnification). The graph shows the quantification of a representative experiment (n = 2 biological replicates). Scale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.003](10.7554/eLife.18746.003)10.7554/eLife.18746.004Figure 1---figure supplement 1.Loss of ATPase activity of Dhh1 does not trigger stress granule formation.(**A**) Dhh1^DQAD^ does not trigger constitutive stress granule formation. Cells co-expressing Pab1-GFP were grown to exponential growth phase, then shifted to glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Scale bar: 5 μm (**B**) *PAT1* mRNAs do not colocalize with PBs in Dhh1 or Dhh1^DQAD^-expressing cells, suggesting functional mRNA decay, but enrich in PBs in *xrn1∆* cells. The indicated strains were grown to exponential growth phase, shifted to either glucose-rich or glucose starvation conditions for 20 min, fixed with paraformaldehyde and processed for smFISH. Depicted is a maximum projection of the central 10 planes of a 3D image. Insets show representative cells (1.67X magnification). Scale bar: 5 µm. (**C**) *PGK1* mRNAs do not colocalize with PBs in Dhh1 or Dhh1^DQAD^-expressing cells, suggesting functional mRNA decay, but enrich in PBs in *xrn1∆* cells. The indicated strains were grown to exponential growth phase, shifted to either glucose-rich or glucose starvation conditions for 20 min, fixed with paraformaldehyde and processed for smFISH as in (**A**). Insets show representative cells (1.67X magnification). ale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.004](10.7554/eLife.18746.004)

Dhh1^DQAD^ PBs form due to a loss of Dhh1 function, rather than a gain-of-function {#s2-2}
----------------------------------------------------------------------------------

Despite their identification nearly 15 years ago, the precise functional role of PBs in *S. cerevisiae* remains poorly understood. Therefore, it is unclear whether PB formation in cells expressing *dhh1^DQAD^* is caused by a loss or gain of Dhh1 function. If Dhh1^DQAD^ PB formation is caused by a loss of Dhh1 function, then the presence of a wild-type copy of *DHH1* should abolish constitutive granule formation. To test this, we expressed wild-type Dhh1-GFP and Dhh1^DQAD^-GFP in either *DHH1* or *dhh1∆* cells in glucose-rich conditions and observed the localization of Dhh1^DQAD^-GFP ([Figure 1B](#fig1){ref-type="fig"}). While Dhh1^DQAD^-GFP -- but not Dhh1-GFP -- robustly formed PBs in *dhh1∆* cells, PBs were no longer present in cells expressing an additional *DHH1* copy, indicating that Dhh1^DQAD^ PB formation is a recessive phenotype, and that the presence of enzymatically active Dhh1 is sufficient to prevent PB formation.

Given that Dhh1^DQAD^ PB formation appeared to be due to a loss-of-function rather than a gain-of-function, one possible explanation for the constitutive formation of PBs could be a block in mRNA decay in *dhh1^DQAD^*cells, similar to *dcp1∆* or *xrn1∆* cells ([@bib68]; [@bib64]). In order to directly interrogate whether loss of the ATPase activity of Dhh1 disrupted mRNA turnover, we tested the functionality of Dhh1^DQAD^ in mRNA decay using a previously established tether-based functional assay. We and others have observed that tethering Dhh1 to a reporter mRNA using the bacteriophage PP7 or MS2 systems is sufficient to stimulate the decay of a tethered mRNA ([@bib9]; [@bib67]). We expressed wild-type Dhh1, Dhh1^DQAD^, or GFP as a PP7 coat protein (PP7CP) fusion protein in *dhh1∆* cells containing a single stem loop (PP7L) engineered into the 3'UTR of the *FBA1* gene ([Figure 1C](#fig1){ref-type="fig"}) and assessed steady state mRNA levels by qPCR. As expected, tethering Dhh1-PP7CP to *FBA1* mRNA caused an 80% reduction of *FBA1* mRNA levels compared with GFP-tethered mRNA ([@bib9]). In comparison, tethering Dhh1^DQAD^ showed a partial attenuation of mRNA decay, with *FBA1* levels decreasing by 55%, ([Figure 1C](#fig1){ref-type="fig"}) ([@bib9]), indicating that Dhh1^DQAD^ is capable of stimulating mRNA decay.

While tethering Dhh1^DQAD^ to an mRNA demonstrated that this variant can function in mRNA decay, it does not address whether Dhh1^DQAD^ PBs can degrade mRNAs. Therefore, we performed single molecule mRNA fluorescence *in situ* hybridization (smFISH) to examine if Dhh1^DQAD^ PBs show hallmarks of mRNA decay. Log-phase *DHH1, dhh1^DQAD^*, and *xrn1∆* cells were shifted into glucose starvation media, and the mRNA localization of *FBA1*, an essential glycolytic gene, was analyzed ([Figure 1D](#fig1){ref-type="fig"}). In *xrn1∆* cells, 54% of *FBA1* mRNAs colocalized with a Dcp2-GFP PB marker in cells grown in glucose-rich conditions and this colocalization was further increased to 75% following glucose starvation. In contrast, only 11% of *FBA1* mRNAs colocalized with PB foci in glucose-starved cells expressing wild-type *DHH1*, consistent with the notion that PBs are sites of mRNA decay, rather than mRNA storage. In cells expressing *dhh1^DQAD^*, *FBA1* mRNA showed a modest overlap with Dcp2-GFP -- around 20% in glucose-rich conditions, and 22% following glucose starvation. Similar results were obtained in smFISH experiments with mRNAs coding for *GFA1*, which functions in chitin biosynthesis ([@bib42]) ([Figure 1E](#fig1){ref-type="fig"}), *PAT1*, which is involved in mRNA decapping ([@bib4]) ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}), and the phosphoglycerate kinase *PGK1* ([@bib36]) ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}) in *DHH1*, *dhh1^DQAD^*, and *xrn1∆* cells. Our tethering experiments, together with the difference in mRNA accumulation between Dhh1^DQAD^ PBs and PBs in *xrn1∆* cells, suggest that Dhh1^DQAD^ PB formation is likely not due to a complete failure to degrade mRNAs. However, some mRNAs show slower turnover in the presence of Dhh1^DQAD^ ([@bib9]). Therefore, reduced decay kinetics may cause mRNAs to persist for longer in PBs, which may in part contribute to the formation of Dhh1^DQAD^ PBs in the absence of stress.

An ATP-bound, RNA-bound conformation of Dhh1 is critical for PB assembly {#s2-3}
------------------------------------------------------------------------

Our data so far indicate that loss of ATPase activity by Dhh1 triggers formation of *bona fide* PBs, suggesting that Dhh1 is ATP bound in PBs. We therefore tested whether ATP binding is required for PB localization of Dhh1. Wild-type Dhh1 or a previously characterized ATP-binding mutant of Dhh1 (Dhh1^F66R,\ Q73A^, henceforth Dhh1^Q-motif^) were co-expressed along with Dcp2-mCherry and localization was monitored in glucose-rich or glucose starvation conditions. Dhh1^Q-motif^ showed a strong defect in PB formation ([Figure 2A](#fig2){ref-type="fig"}), consistent with prior observations ([@bib19]), and also as evidenced by a reduction in PB localization of Dcp2, Xrn1, Dcp1, and Edc3 ([Figure 2---figure supplement 1A--C](#fig2s1){ref-type="fig"}) demonstrating that ATP binding by Dhh1 is required for robust PB formation. We also tested the functionality of Dhh1^Q-motif^ using our tethering assay, and saw that Dhh1^Q-motif^ did not show any obvious defects in mRNA decay when tethered to *FBA1* mRNA ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}).10.7554/eLife.18746.005Figure 2.ATP-bound, RNA-bound Dhh1 is required for robust PB formation.(**A**) Disruption of ATP-binding activity of Dhh1 interferes with PB formation. Wild-type Dhh1 or Dhh1^Q-motif^ was co-expressed from a plasmid as a GFP fusion protein in *dhh1∆* cells along with Dcp2-mCherry as a PB marker and grown to exponential growth phase, then shifted to either glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Images were also acquired using wide-field microscopy and PB formation was quantified using Diatrack 3.5 particle tracking software (see Materials and methods). Graphs represent average Dhh1-GFP or Dcp2-mCherry foci number per cell (n=3 biological replicates, \>800 cells per experiment). Error bars represent SD. A student's t-test comparing Dhh1 and Dhh1^Q-motif^ is shown. Asterisks indicate p\<0.005. Scale bar: 5 µm. (**B**) Disruption of RNA binding activity of Dhh1 interferes with PB formation. Wild-type or mutant Dhh1 was co-expressed from a plasmid as a GFP fusion protein in *dhh1∆* cells along with Dcp2-mCherry as a PB marker and treated as in (A). Scale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.005](10.7554/eLife.18746.005)10.7554/eLife.18746.006Figure 2---figure supplement 1.Loss of ATP binding and RNA binding by Dhh1 disrupts PB localization of other PB factors.Xrn1-GFP (**A**), Dcp1-GFP (**B**), or Edc3-GFP (**C**) was co-expressed in *dhh1∆* cells along with *pDHH1-TAP, pDHH1^Q-motif^-TAP*, or p*DHH1^3X-RNA^-TAP* and Dcp2-mCherry as a PB marker and treated as in [Figure 2A](#fig2){ref-type="fig"}. A student's t-test comparing *DHH1* and either *dhh1*^Q-motif^ or *dhh1^3X-RNA^* is shown. Asterisks indicate p\<0.005 (\*\*\*), or p\<0.05 (\*). Scale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.006](10.7554/eLife.18746.006)10.7554/eLife.18746.007Figure 2---figure supplement 2.Disruption of RNA-binding, but not ATP-binding, affects the ability of tethered Dhh1 to promote mRNA decay.(**A**) Dhh1^Q-motif^ is functional in mRNA decay when tethered to an mRNA. Dhh1 or Dhh1^Q-motif^ was co-expressed as a PP7CP fusion protein in *dhh1∆* cells expressing *FBA1-PP7L. FBA1* mRNA levels were measured by qPCR and normalized to *ACT1* mRNA. Graphs show mean mRNA levels from three independent experiments of biological triplicate samples. Error bars represent SD. A student\'s t-test comparing Dhh1 and Dhh1^Q-motif^ is shown. (**B**) Loss of RNA-binding activity disrupts degradation of a Dhh1-tethered mRNA. Dhh1 or Dhh1^3X-RNA^ was co-expressed as a PP7CP fusion protein in *dhh1∆* cells expressing *FBA1-PP7L. FBA1* mRNA levels were measured by qPCR and normalized to *ACT1* mRNA. Graphs show mean mRNA levels from three independent experiments of biological triplicate samples. Error bars represent SD. A student's t-test comparing Dhh1 and Dhh1^3X-RNA^ is shown. Asterisks indicate p\<0.005. (**C**) Wild-type and Dhh1 mutant proteins are expressed to similar levels. Western blot of Dhh1 and Dhh1 mutant protein expression from cells in exponential growth phase from [Figure 2A and B](#fig2){ref-type="fig"}. Dhh1 was detected using an anti-Dhh1 antibody. Hxk1 was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.007](10.7554/eLife.18746.007)

How does the catalytic activity of Dhh1 contribute to PB formation? Given that ATP-bound Dhh1 binds mRNA in a sequence-independent manner with nanomolar affinity ([@bib19]; [@bib21]), one plausible model is that Dhh1^DQAD^ binds to mRNA, but is unable to dissociate from it in the absence of ATP hydrolysis, ultimately leading to constitutive PB formation. To test this possibility, we generated an RNA binding mutant of Dhh1, Dhh1^3X-RNA^, with alanine substitutions at three residues in the C-terminal RecA domain that are important for RNA binding (R322A, S340A, R370A) ([@bib19]). Wild-type Dhh1, Dhh1^DQAD^, Dhh1^3X-RNA^, and a Dhh1^DQAD/3X-RNA^-GFP double mutant were co-expressed with Dcp2-mCherry in glucose-rich conditions and PB formation was monitored. While Dhh1^DQAD^ cells formed PBs as expected ([Figure 2B](#fig2){ref-type="fig"}, left panel), combining ATPase-dead and RNA-binding mutations in *cis* in the Dhh1^DQAD/3X-RNA^ mutant abolished constitutive PB formation. In addition, both Dhh1^3X-RNA^ and Dhh1^DQAD/3X-RNA^ mutants showed a strong reduction of PB formation in glucose starvation conditions ([Figure 2B](#fig2){ref-type="fig"}, right panel). In addition, several other PB components showed strong defects in PB localization in cells expressing *dhh1^3X-RNA^* ([Figure 2---figure supplement 1A--C](#fig2s1){ref-type="fig"}). Notably, all Dhh1 mutant proteins were expressed to similar levels in these experiments ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). Next, we examined whether disruptions in RNA binding by Dhh1 also affected Dhh1 function in mRNA decay using our tethering assay ([Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). Dhh1^3X-RNA^ caused only a \~30% reduction in tethered *FBA1* mRNA levels, demonstrating that disruption of the mRNA decay activity of Dhh1 per se is not sufficient to trigger PB formation. Overall, we conclude that Dhh1 in its ATP-bound state promotes PB formation and that PB assembly requires RNA binding by Dhh1.

The requirements of ATP and RNA binding by Dhh1 for robust PB formation would predict that deletion of *DHH1* should also cause a reduction in PB formation. However, previous reports suggested that *dhh1∆* cells did not show strong defects in PB assembly ([@bib6]; [@bib68]). To carefully assess the effects of the deletion of *DHH1* on PB formation, we utilized the Diatrack particle tracking software ([@bib71]) which allows for an unbiased, automated, and accurate quantitation of foci formation (see Materials and methods). Analysis of greater than 1000 cells per experiment revealed a nearly 80% reduction of the Dcp2-mCherry foci number per cell in *dhh1∆* compared to wild-type cells during glucose starvation ([Figure 2B](#fig2){ref-type="fig"}). Together, our results demonstrate that Dhh1 is required for robust PB formation.

Dynamics of other processing body components are not affected by loss of Dhh1 ATPase activity {#s2-4}
---------------------------------------------------------------------------------------------

Given that loss of Dhh1 ATPase activity drives constitutive PB assembly and abolishes Dhh1 recycling from PBs ([@bib9]), we asked if Dhh1^DQAD^ also affects the dynamic localization of other mRNA decay factors to PBs. To address this question, we performed fluorescence recovery after photobleaching (FRAP) experiments ([Figure 3A](#fig3){ref-type="fig"}). Cells expressing either wild-type Dhh1 or Dhh1^DQAD^ were shifted to glucose-free media to allow PBs to form, and the recovery of GFP-tagged mRNA decay factors within photobleached PBs was measured over time. Consistent with our previous work, Dhh1-GFP PB fluorescence recovered to roughly 80% within 1 min, while the Dhh1^DQAD^-GFP signal did not, suggesting that Dhh1 ATP hydrolysis is required for Dhh1 to shuttle in and out of PBs ([@bib9]). In contrast, the dynamics of several mRNA decay factors, namely Dcp1, Dcp2, Edc3, and Xrn1, remained unchanged in cells expressing Dhh1^DQAD^ compared with Dhh1. The mRNA decay factors observed showed two distinct FRAP profiles: Xrn1-GFP showed dynamic PB localization in *DHH1* and *dhh1^DQAD ^*cells, while Dcp1, Dcp2, and Edc3 showed a static PB localization profile. The limited recovery seen for Dcp1 and Dcp2 is in agreement with previous FRAP measurements in mammalian cells ([@bib1], [@bib2]), and indicates that these factors are likely resident PB proteins. Thus, with the exception of Dhh1 itself, the dynamics of all tested PB components were not significantly altered by the loss of Dhh1's ATPase activity.10.7554/eLife.18746.008Figure 3.Loss of the ATPase activity of Dhh1 disrupts PB dynamics.(**A**) Loss of the ATPase activity of Dhh1 does not alter the dynamics of known PB components. Fluorescence recovery after photobleaching experiments (FRAP) were performed on cells expressing the indicated GFP-tagged PB component. Cells were glucose starved for 20 min to allow PBs to form, then PBs were bleached and recovery of GFP fluorescence to the PB was followed over time. Recovery of PB components is presented as an averaged data plot of FRAP recovery curves from three independent experiments (n \> 8 PBs per experiment, typically \~12 PBs per experiment). Error bars represent SD. (**B**) The ATPase activity of Dhh1 is required for proper PB disassembly. *dhh1∆* cells expressing Dhh1-GFP or Dhh1^DQAD^-GFP were glucose starved for 30 min to allow PBs to form and then treated with either 50 μg/mL cycloheximide or solvent only (DMSO) for 2 hr and disappearance of Dhh1-GFP or Dhh1^DQAD^-GFP foci per cell was monitored for 2 hr. Each time point image is a maximum-projection of 8 z-stacks at a distance of 0.4 µm. The graph shows foci number per cell measurements for Dhh1 and Dhh1^DQAD^ normalized to 1 to account for differences in PB formation between Dhh1 and Dhh1^DQAD^ (n = 3 biological replicates, \>100 cells). Error bars represent SEM. Scale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.008](10.7554/eLife.18746.008)10.7554/eLife.18746.009Figure 3---figure supplement 1.Loss of ATPase activity of Dhh1 disrupts the PB dynamics of other PB components.(**A**) Loss of ATPase activity of Dhh1 affects disassembly of Dcp2 foci. Dcp2-mCherry was expressed in *dhh1∆* cells co-expressing Dhh1-GFP or Dhh1^DQAD^-GFP from a plasmid, and cells were glucose starved for 30 min to allow PBs to form, followed by treatment with either 50 μg/mL cycloheximide or solvent only (DMSO) for 2 hr. Disappearance of Dcp2-mCherry foci over time is monitored (n = 3 biological replicates). Each time point image is a maximum-projection of 8 z-stacks at a distance of 0.4 µm. Scale bar: 5 µm (**B**) Two-hour cycloheximide treatment does not disrupt cell viability. The indicated cells were glucose starved for 30 min, and then treated with or without 50 μg/mL cycloheximide and 5-fold serial dilutions were plated on SD (-URA) + 2% dextrose media.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.009](10.7554/eLife.18746.009)

FRAP experiments allowed characterization of Dhh1^DQAD^ and wild-type Dhh1 PB dynamics on a sub-minute time scale. To examine the dynamicity of these granules over a longer period, we also treated cells with cycloheximide, which disrupts PB formation, likely by trapping mRNAs on polysomes and preventing their entry into PBs ([@bib40]; [@bib69]). Cells expressing either Dhh1-GFP or Dhh1^DQAD^-GFP and Dcp2-mCherry were grown to mid-log phase and shifted to glucose-free media for 30 min to allow PBs to form, and then treated with cycloheximide for up to 2 hr and PB disassembly was monitored over time ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). While Dhh1-GFP showed roughly 60% disassembly of PBs after 20 min following cycloheximide treatment versus no treatment or solvent-only ([Figure 3B](#fig3){ref-type="fig"}, [Videos 1](#media1){ref-type="other"} and [2](#media2){ref-type="other"} ), Dhh1^DQAD^ PB disassembly occurred significantly slower, with 60% disassembly occurring around 80 min after cycloheximide treatment ([Figure 3B](#fig3){ref-type="fig"}, [Videos 3](#media3){ref-type="other"} and [4](#media4){ref-type="other"}). Notably, 2 hr cycloheximide treatment did not adversely affect cell viability ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). The disassembly of Dhh1^DQAD^ PBs following cycloheximide treatment suggests that these structures, like wild-type PBs, are RNA-dependent structures. However, the slower disassembly kinetics of Dhh1^DQAD^ PBs, coupled with the dampened recycling of Dhh1^DQAD^, indicates that ATPase activity of Dhh1 is critical for normal PB disassembly, for instance, by facilitating release of Dhh1 from its mRNA client.Video 1.Cycloheximide treatment causes wild-type PB disassembly.*dhh1∆* cells expressing Dhh1-GFP from a plasmid were glucose starved for 30 min to allow PBs to form, and were then treated with 50 µg/mL cycloheximide and disappearance of Dhh1-GFP foci was monitored (5 min intervals; movie played at 5 fps). Each frame represents a maximum-projection of 8 z-stacks at a distance of 0.4 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.010](10.7554/eLife.18746.010)10.7554/eLife.18746.010Video 2.DMSO treatment does not trigger wild-type PB disassembly.*dhh1∆* cells expressing Dhh1-GFP from a plasmid were glucose starved for 30 min to allow PBs to form, and were then mock treated with DMSO and disappearance of Dhh1-GFP foci was monitored (5 min intervals; movie played at 5 fps). Each frame represents a maximum-projection of 8 z-stacks at a distance of 0.4 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.011](10.7554/eLife.18746.011)10.7554/eLife.18746.011Video 3.Dhh1^DQAD^ PBs disassemble more slowly than wild-type PBs following cycloheximide treatment.*dhh1∆* cells expressing Dhh1^DQAD^-GFP from a plasmid were glucose starved for 30 min to allow PBs to form, and were then treated with 50 µg/mL cycloheximide and disappearance of Dhh1^DQAD^-GFP foci was monitored (5 min intervals; movie played at 5 fps). Each frame represents a maximum projection of 8 z-stacks at a distance of 0.4 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.012](10.7554/eLife.18746.012)10.7554/eLife.18746.012Video 4.DMSO treatment does not trigger Dhh1^DQAD^ PB disassembly.*dhh1∆* cells expressing Dhh1^DQAD^-GFP from a plasmid were glucose starved for 30 min to allow PBs to form, and were then mock treated with DMSO and disappearance of Dhh1^DQAD^-GFP foci was monitored (5 min intervals; movie played at 5 fps). Each frame represents a maximum projection of 8 z-stacks at a distance of 0.4 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.013](10.7554/eLife.18746.013)10.7554/eLife.18746.013

Dhh1 ATPase activity is stimulated *in vitro* and *in vivo* by Not1 {#s2-5}
-------------------------------------------------------------------

So far, our data reveal that the ATPase cycle of Dhh1 is a critical regulator of PB dynamics, and that Dhh1 in its ATP-bound state promotes PB formation. Interestingly, Dhh1 alone is a very poor ATPase *in vitro* ([@bib19]; [@bib70]). However, DDX6, the mammalian homolog of Dhh1, can be stimulated by CNOT1, the central scaffold subunit of the CCR4-NOT complex ([@bib47]). Based on our data, we would therefore predict that Not1 should promote the disassembly of PBs by stimulating the ATPase cycle of Dhh1. To test this prediction, we first examined whether *S. cerevisiae* Not1, like its mammalian homolog, stimulated the ATPase activity of Dhh1 *in vitro*. We recombinantly expressed and purified full-length Dhh1 and Dhh1^DQAD^ and performed *in vitro* ATPase assays to assess the enzymatic activity of Dhh1 in the presence or absence of polyU RNA and recombinant Not1^MIF4G^ (amino acids 754--1000). Similar to previous observations, we could not detect an intrinsic ATPase activity for Dhh1 alone. Dhh1 was weakly stimulated by polyU RNA ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}) ([@bib19]), whereas addition of Not1^MIF4G^ alone had little effect ([Figure 4A](#fig4){ref-type="fig"}). However, addition of polyU RNA and increasing concentrations of Not1^MIF4G^ robustly stimulated the ATPase activity of Dhh1, but not Dhh1^DQAD^ ([Figure 4A](#fig4){ref-type="fig"}). In contrast, Gle1, another MIF4G-fold protein that stimulates the activity of Dbp5, a related DEAD-box ATPase that functions in mRNA export ([@bib48]; [@bib65]), had no effect on Dhh1 ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Furthermore, Not1 was unable to stimulate the catalytic activity of Dbp5 ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}), demonstrating that Not1 specifically activates the ATPase cycle of Dhh1 *in vitro*.10.7554/eLife.18746.014Figure 4.The ATPase activity of Dhh1 is stimulated *in vitro *and *in vivo* by Not1.(**A**) ATPase activity of Dhh1 is stimulated by Not1. The ATPase activity of full-length Dhh1 or Dhh1^DQAD^ was measured with increasing concentrations of Not1^MIF4G^. Graphs represent average ATPase activity (n=3). Error bars represent SD. (**B**) Disruption of Dhh1 interaction with the MIF4G region of Not1 by mutation of conserved residues in Dhh1. TAP-tagged Dhh1, Dhh1^5X-Not^, or untagged Dhh1 were purified from cells in exponential growth phase using IgG-coupled magnetic beads and co-purifying Not1-3HA was detected by Western blot. Quantification of Not1 to Dhh1 ratio is plotted with SEM (n=5 biological replicates). A representative Western blot is shown. A student's t-test comparing Dhh1 and Dhh1^5X-Not^ is shown. Asterisks indicate p\<0.01. (**C**) Mutations in the Not1-binding surface of Dhh1 trigger constitutive PB assembly. Wild-type or mutant Dhh1 was co-expressed from a plasmid as a GFP fusion protein in *dhh1∆* cells along with Dcp2-mCherry as a PB marker and grown to exponential growth phase, then shifted to either glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Images were also acquired using wide-field microscopy and PB formation was quantified using Diatrack 3.5 particle tracking software. Graphs represent the average Dhh1-GFP foci or Dcp2-mCherry foci number per cell (n=3 biological replicates, \>800 cells per experiment). Error bars represent SD. Scale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.014](10.7554/eLife.18746.014)10.7554/eLife.18746.015Figure 4---figure supplement 1.Not1 is a specific activator of the ATPase activity of Dhh1.(**A**) ATPase activity of Dhh1 is weakly stimulated by RNA. ATPase activity of full-length Dhh1 was measured with increasing concentrations of polyU RNA. Graphs represent average ATPase activity (n=3 biological replicates). Error bars represent SD.(**B**) Not1 is a specific activator of Dhh1. ATPase activity of full-length Dhh1 or Dbp5 was measured in the presence of the indicated protein. Graphs represent average ATPase activity (n=3 biological replicates). Error bars represent SD. (**C**) Not1 binding is diminished in a ATP-binding mutant of Dhh1. TAP-tagged Dhh1 or Dhh1^Q-motif^ were purified from cells in exponential growth phase using IgG-coupled magnetic beads and co-purifying Not1-3HA was detected by Western blot. Quantification of Not1 to Dhh1 ratio is plotted with SEM (n=4 biological replicates). A representative Western blot is shown. A student's t-test comparing Dhh1 and Dhh1^Q-motif^ is shown. Asterisks indicate p\<0.01. (**D--F**) Known PB components localize to Dhh1^5X-Not^ foci. Xrn1-GFP (**D**), Dcp1-GFP (**E**), or Edc3-GFP (**F**) was co-expressed in *DHH1* or *dhh1^5X-Not^*cells, along with Dcp2-mCherry as a PB marker. Cells were grown to exponential growth phase, then shifted to glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Images were also acquired using wide-field microscopy and PB formation was quantified using Diatrack 3.5 particle tracking software. Graphs represent the average foci number per cell (n = 3 biological replicates, \>800 cells per experiment). Error bars represent SD. Scale bar: 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.015](10.7554/eLife.18746.015)10.7554/eLife.18746.016Figure 4---figure supplement 2.Tethered Dhh1 does not require ATPase activation by Not1 to promote mRNA decay.(**A**) Dhh1^5X-Not^ does not show a significant defect in mRNA decay when tethered to an mRNA. Dhh1 or Dhh1^5X-Not^ was co-expressed as a PP7CP fusion protein in *dhh1∆* cells expressing *FBA1-PP7L. FBA1* levels were measured by qPCR and normalized to *ACT1* mRNA. Graphs show mean mRNA levels from three independent experiments of biological triplicate samples. Error bars represent SD. (**B**) Wild-type and Dhh1 mutant proteins are expressed to similar levels. Western blot of Dhh1 and Dhh1 mutant protein expression from cells in exponential growth phase. Dhh1 was detected using an anti-GFP antibody. Hxk1 was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.016](10.7554/eLife.18746.016)

If Not1 also stimulates Dhh1 ATPase activity *in vivo* then our model would predict that disruption of the Dhh1-Not1 interaction should lead to constitutive PB formation. To interfere with the Dhh1-Not1 interaction, we generated a mutant with amino acid substitutions in conserved residues on three distinct surfaces of Dhh1 (Dhh1^R55E,\ F62E,\ Q282E,\ N284E,\ R355E^, henceforth Dhh1^5X-Not^) that are predicted to affect binding to Not1, based on previous structural data ([@bib10]; [@bib47]). Indeed, Dhh1^5X-Not^ showed a marked reduction in Not1 binding in immunoprecipitation experiments compared with wild-type Dhh1 ([Figure 4B](#fig4){ref-type="fig"}), indicating that these amino acid residues are important for the interaction between Dhh1 and Not1. Given that ATP binding by Dhh1 is likely a prerequisite for PB formation, we also examined whether ATP binding by Dhh1 was needed for the interaction with Not1. As shown in [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}, Dhh1^Q-motif^ was defective in Not1 binding, suggesting that ATP-bound Dhh1 is needed for robust interaction with Not1.

To examine the importance of the Dhh1-Not1 interaction in PB formation, we co-expressed GFP-tagged Dhh1, Dhh1^DQAD^, or Dhh1^5X-Not^ along with Dcp2-mCherry, grew cells into mid-log phase and examined Dhh1 localization. Dhh1^5X-Not^ triggered Dhh1 and Dcp2 colocalization in cytoplasmic granules in glucose-rich conditions, similar to catalytically dead Dhh1^DQAD^([Figure 4C](#fig4){ref-type="fig"}). All Dhh1 mutant proteins were expressed to similar levels in these experiments ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}). Two lines of evidence suggest that these granules are indeed *bona fide* PBs. First, Dhh1^5X-Not^ granules contained several other known PB proteins -- including Xrn1, Dcp1, and Edc3 -- in both glucose-rich and glucose starvation conditions ([Figure 4---figure supplement 1D--F](#fig4s1){ref-type="fig"}). Second, Dhh1^5X-Not^ granule assembly required robust RNA binding activity, as a Dhh1^5X-Not/3X-RNA^ mutant showed a dramatic defect in PB formation in both glucose-rich and glucose starvation conditions ([Figure 4C](#fig4){ref-type="fig"}). Of note, the Dhh1^5X-Not^ mutant did not show a defect in mRNA decay using our tethering assay ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}), suggesting that PB formation in cells expressing Dhh1^5X-Not^ is not due to a block in mRNA degradation.

Several other decay factors have been shown to interact with the C-terminal RecA domain of Dhh1 ([@bib63]; [@bib70]). Thus, it was conceivable that the Dhh1^5X-Not^ mutant not only disrupted the interaction between Dhh1 and Not1, but also with additional factors, which may contribute to PB formation. We therefore generated a *NOT1* allele, *not1*^9X-Dhh1^ -- with substitutions at conserved amino acid residues that were previously shown to mediate interaction between CNOT1 and DDX6 (F791A, N795A, K804A, E832R, N834A, Y835A, K962A, F967A, and E970A) ([@bib10]; [@bib47]; [@bib59]). We co-expressed Not1 or Not1^9X-Dhh1^ along with Dhh1-GFP and Dcp2-mCherry and shifted cells into media with and without glucose to evaluate PB formation. While cells expressing wild-type Not1 showed diffuse Dhh1 and Dcp2 localization, the Not1^9X-Dhh1^ mutant triggered colocalization of Dhh1 and Dcp2 into distinct foci in both glucose-rich and glucose starvation conditions ([Figure 5](#fig5){ref-type="fig"}). While granule induction in these cells was less pronounced than in Dhh1^DQAD^or Dhh1^5X-Not^ cells ([Figure 4C](#fig4){ref-type="fig"}) in glucose-rich conditions, these foci contained other known PB components ([Figure 5---figure supplement 1A--C](#fig5s1){ref-type="fig"}), suggesting they are *bona fide* PBs. Additionally, Not1^9X-Dhh1^ was expressed at wild-type Not1 levels ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). In summary, we conclude that the ATPase cycle of Dhh1 is a critical regulator of PB formation, and that Not1 regulates the ATPase activity of Dhh1 *in vivo*, preventing PB formation in glucose-rich conditions.10.7554/eLife.18746.017Figure 5.Mutations in Dhh1-binding surface of Not1 trigger constitutive PB assembly.Not1 or Not1^9X-Dhh1^ was co-expressed with Dhh1-GFP and Dcp2-mCherry and grown to exponential growth phase, then shifted to either glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Images were also acquired using wide-field microscopy and PB formation was quantified using Diatrack 3.5 particle tracking software (see Materials and methods). Graphs represent average Dhh1-GFP foci or Dcp2-mCherry foci number per cell (n=3 biological replicates, \>800 cells per experiment). Error bars represent SD. Scale bar: 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.017](10.7554/eLife.18746.017)10.7554/eLife.18746.018Figure 5---figure supplement 1.Not19X-Dhh1 triggers PB assembly.(**A--C**) Known PB components localize to Not1^9X-Dhh1^ foci. Xrn1-GFP (**A**), Dcp1-GFP (**B**), or Edc3-GFP (**C**) was co-expressed in *NOT1*, or *not1^9X-Dhh1^*cells, along with Dcp2-mCherry as a PB marker. Cells were grown to exponential growth phase, then shifted to glucose-rich or glucose starvation conditions for 20 min and observed by confocal microscopy. Images were also acquired using wide-field microscopy and PB formation was quantified using Diatrack 3.5 particle tracking software. Graphs represent average foci number per cell (n=3 biological replicates, \>800 cells per experiment). Error bars represent SD. A student\'s t-test comparing localization between Not1 and Not1^9x-Dhh1^ is shown. Asterisks indicate p\<0.005 (\*\*\*), or p\<0.05 (\*). Scale bar: 5 μm (**D**) Not1^9X-Dhh1^ mutant is expressed to wild-type Not1 levels. Western blot of Not1 or Not1^9X-Dhh1^ mutant protein expression from cells in exponential growth phase. Not1 was detected using Rabbit IgG, and Dhh1 was detected using an anti-Dhh1 antibody. Hxk1 was used as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.018](10.7554/eLife.18746.018)

Dynamics of Dhh1 PB recycling can be recapitulated *in vitro* {#s2-6}
-------------------------------------------------------------

To better understand how the ATPase cycle of Dhh1 regulates PB formation, we attempted to reconstitute granule formation *in vitro*. Remarkably, recombinant Dhh1, in the presence of RNA and ATP, readily formed droplets in solution ([Figure 6A and B](#fig6){ref-type="fig"}). These droplets showed hallmarks of liquid-liquid phase separation, undergoing growth and fusion events and reversible deformation ([Video 5](#media5){ref-type="other"}), consistent with the reported biophysical behavior of PBs ([@bib40]). Dhh1 droplet formation was RNA-dependent, as no droplets formed when RNA was omitted ([Figure 6A](#fig6){ref-type="fig"}), and the number and size of droplets rapidly decreased upon addition of RNase A ([Figure 6C](#fig6){ref-type="fig"}, [Video 6](#media6){ref-type="other"}), but not with buffer alone ([Figure 6C](#fig6){ref-type="fig"}, [Video 7](#media7){ref-type="other"}).10.7554/eLife.18746.019Figure 6.Dhh1 PB dynamics can be recapitulated *in vitro.*(**A**) Formation of liquid Dhh1-droplets depends on the presence of the RNA analog polyuridylic acid (polyU) and increases with increasing protein concentration. Recombinant mCherry-tagged Dhh1 was diluted into a low salt buffer and incubated at 4°C for 1 hr. Formation of liquid droplets was observed by fluorescence microscopy. Scale bar: 10 μm. (**B**) Dhh1 liquid droplet formation requires ATP. Dhh1 liquid droplets were formed as in (A), in the presence or absence of ATP and the creatine kinase ATP regeneration system. Scale bar: 20 μm. (**C**) Addition of Not1^MIF4G^ or RNase A, but not buffer alone, dissolves pre-formed Dhh1 liquid droplets. Dhh1 liquid droplets were pre-formed for 20 min at 4°C, followed by the addition of 5 µM Not1^MIF4G^ or RNase A. Scale bar: 10 μm. (**D, E**) Pre-incubation with Not1^MIF4G^prevents formation of Dhh1, but not Dhh1^DQAD^ liquid droplets. Reactions were imaged after 1h incubation at 4°C. Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.019](10.7554/eLife.18746.019)10.7554/eLife.18746.020Figure 6---figure supplement 1.Single point mutants in the ATP binding site of Dhh1 affect PB assembly and liquid droplet formation.(**A**) Single mutations in the Q-motif of Dhh1 show minor defects in PB formation. Wild-type Dhh1, Dhh1^F66R^ or Dhh1^Q73A^ were expressed from a plasmid as a GFP fusion protein in *dhh1∆* cells along with Dcp2-mCherry as a PB marker and grown to exponential growth phase, then shifted to either glucose-rich or glucose starvation conditions for 20 min and observed by wide-field microscopy. PB formation was quantified using Diatrack 3.5 particle tracking software. Graphs represent average Dhh1-GFP or Dcp2-mCherry foci number per cell (n=3 biological replicates, \>300 cells per experiment). Error bars represent SD. A student's t-test comparing Dhh1^F66R^ or Dhh1^Q73A^ with Dhh1 is shown. Scale bar: 5 µm (**B**) Dhh1 liquid droplet formation requires ATP binding. Recombinant mCherry-tagged Dhh1, Dhh1^DQAD^ or Dhh1^F66R^ were diluted into a low salt buffer and incubated at 4°C for 1 hr in the presence of ATP and 0.075 mg/mL polyU. Formation of liquid droplets was observed by fluorescence microscopy. Scale bar: 10 μm**DOI:** [http://dx.doi.org/10.7554/eLife.18746.020](10.7554/eLife.18746.020)Video 5.Purified Dhh1, ATP, and RNA form liquid-like droplets *in vitro*.Droplets were formed for 2 min with 6.25 µM Dhh1-mCherry and 0.075 mg/mL polyU in a final volume of 20 µL and imaged live in a time course (5 s intervals; movie played at 7 fps). Fusion events can be observed that lead to rounding up of the new droplet to assume a spherical shape.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.021](10.7554/eLife.18746.021)10.7554/eLife.18746.021Video 6.RNase A treatment dissolves Dhh1 liquid droplets.Droplets were formed for 20 min from 6.25 µM Dhh1-mCherry and 0.075 mg/mL polyU in a final volume of 20 µL. The imaging time course started (10 s intervals; movie played at 3 fps). After few frames, RNase A was added (1.5 µL of a 0.04 µg/mL stock solution, which was prepared by dilution of a 10 mg/mL stock solution in Not1^MIF4G^ storage buffer) to the pre-formed Dhh1 droplets.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.022](10.7554/eLife.18746.022)10.7554/eLife.18746.022Video 7.Addition of Not1^MIF4G^ storage buffer does not affect Dhh1 liquid droplet formation.Droplets were formed for 20 min from 6.25 µM Dhh1-mCherry and 0.075 mg/mL polyU in a final volume of 20 µL. The imaging time course was started (10 s intervals; movie played at 3 fps). After a few frames, 1.5 µL Not1^MIF4G^ storage buffer was added to the pre-formed Dhh1 droplets.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.023](10.7554/eLife.18746.023)10.7554/eLife.18746.023

Next, we examined the role of ATP binding by Dhh1 in droplet formation. Despite numerous attempts, we were unable to purify Dhh1^Q-motif^ with sufficient quality for analysis. However, we successfully purified a single Q-motif point mutant, Dhh1^F66R^ ([@bib19]) for use in our *in vitro* assay. While Dhh1^F66R^ showed only a minor defect in PB localization following glucose starvation ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}), this mutant showed a dramatic loss of droplet formation *in vitro* ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Additionally, Dhh1 droplets did not form in the absence of ATP ([Figure 6B](#fig6){ref-type="fig"}), demonstrating that Dhh1 in its ATP-bound form promotes liquid droplet formation.

Given that Not1 promotes PB disassembly *in vivo* by stimulating the ATPase activity of Dhh1, we next examined whether the presence of Not1 also antagonizes Dhh1 liquid droplet formation *in vitro*. Consistent with our *in vivo* data, addition of Not1^MIF4G^ triggered the dissolution of pre-formed Dhh1 liquid droplets ([Figure 6C](#fig6){ref-type="fig"}, [video 8](#media8){ref-type="other"}). Furthermore, no assembly occurred when Not1^MIF4G^ was added before polyU during the assembly reaction ([Figure 6D](#fig6){ref-type="fig"}).Video 8.Addition of Not1^MIF4G^ dissolves Dhh1 liquid droplets.Droplets were formed for 20 min with 6.25 µM Dhh1-mCherry and 0.075 mg/mL polyU in a final volume of 20 µL. The imaging time course was started (10 s intervals; movie played at 3 fps). After a few frames, Not1^MIF4G^ (1.5 µl of a 150 µM stock solution) was added to the pre-formed Dhh1 droplets.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.024](10.7554/eLife.18746.024)10.7554/eLife.18746.024

To determine whether catalytically active Dhh1 was required for droplet dissolution, we also tested the functionality of the ATPase-dead Dhh1^DQAD^ mutant in our *in vitro* assay. While Dhh1^DQAD^ formed droplets to a similar extent as wild-type Dhh1 ([Figure 6E](#fig6){ref-type="fig"}), these structures did not dissolve in the presence of Not1^MIF4G^, supporting the specificity of the observed effect ([Figure 6E](#fig6){ref-type="fig"}). Interestingly, the Dhh1^DQAD^ droplets slightly increased in size and number upon Not1^MIF4G^ addition. It is likely that the MIF4G domain of Not1, like other MIF4G domains, stabilizes a conformation of the two RecA domains which facilitates nucleotide and RNA loading ([@bib48]; [@bib51]), which consequently may enhance droplet formation in the absence of Dhh1\'s ATPase activity. Thus, while other mRNA decay factors contribute to PB formation *in vivo*, this demonstrates that with a minimal number of constituents, namely Dhh1, RNA, and ATP, higher-order dynamic liquid droplets can be formed *in vitro*. These droplets recapitulate several properties of PBs formed *in vivo* such as the dependence on ATP and RNA binding by Dhh1 to form ([Figure 2A and B](#fig2){ref-type="fig"}) as well as the requirement of both a functional Dhh1 ATPase and the MIF4G domain of Not1 for dissolution ([Figures 4C](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}).

Discussion {#s3}
==========

ATPase activity of Dhh1 regulates PB dynamics {#s3-1}
---------------------------------------------

The DEAD-box ATPase Dhh1 and its orthologs play a critical role in translational repression and degradation of cytoplasmic mRNAs. However, how the catalytic activity of Dhh1 contributes to its function has not been well defined. Here, we show that the ATPase activity of Dhh1 regulates the dynamics of PBs in an RNA-dependent manner. Point mutations in Dhh1 that prevent ATP hydrolysis or disrupt the interaction surface with the ATPase activator Not1 were sufficient to trigger aberrant PB formation *in vivo* in the absence of stress ([Figure 4C](#fig4){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}). Furthermore, we can recapitulate this process *in vitro*, as Dhh1 forms dynamic liquid droplets in the presence of RNA and ATP that are dissolved upon addition of the purified MIF4G ATPase activation domain of Not1 ([Figure 6](#fig6){ref-type="fig"}).

Not1 stimulates the activity of Dhh1 *in vitro* and *in vivo* {#s3-2}
-------------------------------------------------------------

The central scaffold of the CCR4-NOT complex, Not1, similar to its mammalian homolog CNOT1, is shown here to be an activator of the catalytic cycle of Dhh1 *in vitro*. Like other known DEAD-box cofactors, Not1 possesses a MIF4G domain ([@bib10]; [@bib47]; [@bib54]; [@bib59]) that is critical for stimulation of Dhh1. In the absence of Not1^MIF4G^ and RNA, we could not detect ATPase activity of Dhh1. Both Dhh1 and DDX6 alone adopt an unusual closed conformation, characterized by extensive intramolecular contacts that are not present in other members of the DEAD-box protein family ([@bib10]; [@bib11]; [@bib47]). Binding of CNOT1 causes a dramatic structural rearrangement, shifting DDX6 into an ATPase-competent state ([@bib47]). However, even the Not1-stimulated activity of Dhh1 remains low ([Figure 4A](#fig4){ref-type="fig"}). Although the rate-limiting step in the catalytic cycle of DEAD-box ATPases often appears to be the release of substrate RNA and ADP/Pi ([@bib8]; [@bib34]; [@bib35]; [@bib74]), it is conceivable that the large conformational change that Dhh1 must undergo in order to bind both Not1 and substrate significantly contributes to the slow ATPase cycle of Dhh1.

While mutations in conserved residues that mediate the interaction between Dhh1 and Not1 triggered constitutive PB formation, these mutants did not completely recapitulate the degree of PB formation seen in cells expressing catalytically dead Dhh1^DQAD^. This may perhaps be due to only a partial loss of stimulation of Dhh1 by Not1 in these mutants. Unfortunately, we were unable to purify these variants as recombinant proteins, and therefore could not determine their effect on ATPase stimulation *in vitro*. Alternatively, there may be additional cellular factors that modulate the catalytic cycle of Dhh1.

Role of RNA and ATP binding activity of Dhh1 in PB formation {#s3-3}
------------------------------------------------------------

In addition to demonstrating a critical role for ATP hydrolysis by Dhh1 in the regulation of PB formation, we also show that both RNA and ATP binding by Dhh1 are critical for PB assembly, consistent with prior observations ([@bib19]). Neither Dhh1^Q-motif^ nor Dhh1^3X-RNA^ mutant cells robustly form PBs following glucose starvation. In addition, mutations that disrupt RNA binding also prevent constitutive PB formation of catalytically dead Dhh1 ([Figure 2B](#fig2){ref-type="fig"}). Remarkably, Dhh1 forms liquid droplets *in vitro* that require both ATP and RNA ([Figure 6](#fig6){ref-type="fig"}), indicating that multimeric assembly of Dhh1 in its ATP-bound state with RNA may drive PB formation. Since DDX6 can oligomerize in both an RNA-dependent and RNA-independent manner ([@bib21]), and given that both Dhh1 and DDX6 exist in molar excess over cytoplasmic mRNA ([@bib28]; [@bib50]), it is conceivable that an ATP-bound conformation of Dhh1 multimerizes on RNA *in vivo*, thereby delivering mRNAs to PBs and seeding PB assembly. Upon ATP hydrolysis, Dhh1 could then return to the cytoplasmic pool to bind and deliver the next mRNA target. However, when ATP hydrolysis is inhibited, such as in Dhh1^DQAD^ or Dhh1^5X-Not^-expressing cells, Dhh1 remains associated with its mRNA client, triggering the formation of constitutive PBs.

Functional role of PBs {#s3-4}
----------------------

Despite an increasing understanding of PB composition, the precise functional role of PBs remains unclear. Given the large number of mRNA decay factors present in PB assemblies, as well as the accumulation of Xrn1-protected polyG-tract-containing mRNAs, PBs were initially proposed to be sites of mRNA decay ([@bib64]; [@bib68]). However, several studies have shown that mRNAs can also stably localize within PBs, raising the question of whether these granules are sites of active mRNA decay or rather of mRNA storage ([@bib37]; [@bib43]; [@bib46]; [@bib77]). It should be noted, however, that in many cases mRNAs were localized to PBs using either the MS2 or PP7 coat protein system, whereby multiple stem loops are engineered into the 3'UTR of transcripts and then visualized using fluorescently tagged coat-protein fusions that recognize these stem loops. Yet, recent data indicate that these stem loop systems may inhibit mRNA decay in budding yeast, and that primarily these stem loop structures -- but not the body of transcripts -- persist in PBs, and cannot be degraded by Xrn1 ([@bib25], [@bib26]; [@bib32]; Heinrich and Weis, unpublished). Our smFISH data are consistent with the hypothesis that active decay occurs within PBs, since none of the four tested mRNAs were enriched in wild-type and Dhh1^DQAD^ PBs in contrast to PBs in *xrn1∆* cells ([Figure 1D--E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1B--C](#fig1s1){ref-type="fig"}). Thus, selective delivery of mRNAs to PBs could enhance their degradation because of the high local concentration of the mRNA decay machinery in PBs. Alternatively, the sequestration of mRNA decay factors and selected mRNAs into PBs could also allow for spatial separation of translation factors from mRNA, preventing translation of messages that would be unproductive during periods of stress.

Increasing relevance of liquid droplets in cell biology, and the role of ATPases in granule formation {#s3-5}
-----------------------------------------------------------------------------------------------------

The formation of mRNPs -- including PBs -- into membrane-less organelles that behave like dynamic liquid droplets has recently emerged as a common mechanism by which cells may further compartmentalize their biochemistry ([@bib29]; [@bib40]; [@bib75]). Furthermore, a variety of different ATP-driven protein machines have also emerged as important regulators of mRNP granule assembly. For example, stress granule (SG) assembly and dynamics are disrupted by loss-of-function alleles in the MCM and RVB helicase complexes, while hypomorphic alleles in the chaperonin-containing T (CCT) complex form more SGs ([@bib38]). Additionally, the AAA+ ATPase Cdc48 was also previously shown to facilitate clearance of SGs ([@bib5]). Our data demonstrate that the DEAD-box ATPase Dhh1 is a critical regulator of PB disassembly *in vivo* and that liquid droplets containing Dhh1 multimers form in the presence of RNA and ATP, which can be dissolved upon induction of ATP hydrolysis *in vitro*. Two biochemical functions are critical for the role of Dhh1 in PB formation both *in vivo* and *in vitro*: (1) Dhh1's affinity for RNA, which may facilitate delivery of mRNA substrates into PBs, and (2) ATP binding, and the tuning of Dhh1's ATPase activity by factors such as Not1. These features of Dhh1 may ultimately be the critical controllers of PB formation and PB turnover. 

The processing body and Dhh1 ATPase cycles {#s3-6}
------------------------------------------

PBs have been extensively studied, yet the molecular mechanisms driving PB formation and disassembly are poorly understood. Our data show that the ATP- and RNA-bound form of Dhh1 promotes PB formation, while Not1 promotes PB disassembly by stimulating the ATPase activity of Dhh1 (for illustration, see model [Figure 7](#fig7){ref-type="fig"}). Still, there are several elements of the PB and Dhh1 ATPase cycle that remain unclear. For example, what leads to PB formation under specific cellular stress conditions? Is this driven by a stress-induced attenuation of translation or increase in mRNA turnover, which leads to an increased number of client mRNAs targeted to PBs? Alternatively, cellular stress may dampen the ATPase activity of Dhh1, for example by regulating the interaction between Dhh1 and Not1, thereby shifting the equilibrium towards the ATP-bound, RNA-bound Dhh1 state. This in turn would then slow down PB disassembly, causing a build up of PB structures.10.7554/eLife.18746.025Figure 7.Model: The ATPase cycle of Dhh1 controls PB assembly and disassembly.An ATP- and RNA-bound conformation of Dhh1 nucleates PB formation, while stimulation of Dhh1's ATPase activity by Not1 promotes granule disassembly.**DOI:** [http://dx.doi.org/10.7554/eLife.18746.025](10.7554/eLife.18746.025)

In addition, the polyA status of Dhh1-bound mRNAs targeted to PBs is also unknown. While deadenylation by CCR4-NOT was previously placed upstream of Dhh1 in the mRNA decay pathway ([@bib15]; [@bib22]), it is unclear whether deadenylation is a prerequisite for targeting mRNAs to PBs. Finally, with respect to the hydrolysis step, does Not1 facilitate recycling of Dhh1 from the PB by promoting the release of Dhh1 from RNA, similar to the function of other DEAD-box activators ([@bib44]; [@bib48]) or does it regulate the interaction with other factors such as scaffold proteins of PBs? Intriguingly, the ATPase cycle of Dhh1 does not seem to influence the recycling of other PB components ([Figure 3A](#fig3){ref-type="fig"}), consistent with the idea that the regulated interaction between Dhh1 and mRNA shifts the balance between PB formation or disassembly.

While Not1 has a well-known role as the central subunit of the major cytoplasmic deadenylase, our work defines a novel function for Not1 in PB disassembly and Dhh1 recycling, which presumably occurs at a late stage in mRNA turnover. Interestingly, there is increasing evidence that the CCR4-NOT complex functions at several other steps during gene expression outside of mRNA decay, including transcription ([@bib30]; [@bib41]; [@bib72]) and translation ([@bib55]; [@bib57]). Future work is needed to address how the activity of this multifunctional protein complex is modulated in order to regulate and coordinate multiple steps of gene expression.

Materials and methods {#s4}
=====================

Construction of yeast strains and plasmids {#s4-1}
------------------------------------------

The strains used in this study are derivatives of W303 and are described in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Yeast deletion strains and C-terminal epitope tagging of ORFs was done by PCR-based homologous recombination, as previously described ([@bib45]). Generation of bacteriophage PP7CP and PP7-loop tagging plasmids was described previously ([@bib9]).

Plasmids for this study are described in [Supplementary file 2A](#SD2-data){ref-type="supplementary-material"}. Mutations in Dhh1 were generated using a QuikChange II site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) using Pfu Ultra or Pfu Turbo. Mutagenic oligonucleotides were designed using the Agilent Technologies primer design platform. Construction of *NOT1-TAP* and *not1^9X-Dhh1^-TAP* integration vectors were made using *NOT1* and *NOT1^(F791A,\ N795A,\ K804A,\ E832R,\ N834A,\ Y835A,\ K962A,\ F967A,\ and\ E970A)^*gene block fragments ordered from Integrated DNA Technologies (IDT, Coralville, IA) that were ligated into the single-integration vector pNH605 by Gibson Assembly (New England Biolabs, Ipswich, MA). Primer sequences for strain construction are listed in [Supplementary file 2B](#SD2-data){ref-type="supplementary-material"}.

Tethering assay {#s4-2}
---------------

Sample preparation was performed as previously described ([@bib9]). Briefly, yeast cells were inoculated overnight in synthetic media containing 2% glucose and grown to saturation. The following morning, cultures were diluted and grown to exponential growth phase (OD~600~ = 0.4--0.8) then collected by centrifugation and lysed in 1X phosphate-buffered saline (PBS) with 0.1% Tween-20 and protease inhibitors. Lysis was performed using a Mini-Beadbeater-96 (BioSpec Products, Inc., Bartlesville, OK) with a 5-minute cycle. The extract was clarified by centrifugation, and RNA was isolated using the RNeasy RNA isolation kit (Qiagen, Hilden, Germany). Resulting RNA samples were stored at −80°C.

RT-qPCR {#s4-3}
-------

RNA was isolated as described above and quantified using a NanoDrop spectrophotometer (Thermo Fischer, Waltham, MA). cDNA was generated by reverse transcription of 1 μg of RNA using a random hexamer oligonucleotide (Invitrogen, Carlsbad, CA) and Superscript II (Invitrogen). Quantitative PCR was performed in real time using the StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA) and a SYBR-Green ROX qPCR Master Mix (Thermo Fischer) supplemented with gene-specific primers as reported in ([@bib9]).

Single molecule fluorescent *in situ* hybridization {#s4-4}
---------------------------------------------------

The indicated strains were inoculated overnight in synthetic media containing 2% glucose and grown to saturation. The following morning, cultures were diluted and grown in synthetic complete media containing 2% glucose at 25°C to exponential growth phase (OD~600~ = 0.6-0.8), then shifted to synthetic complete media with or without glucose for 20 min and fixed for 15 min with 4% paraformaldehyde. Samples were processed for single molecule fluorescence *in situ* hybridization (smFISH) as described in ([@bib33]), with the exception of spheroplasting yeast cells for 20 min using 1% 20T zymolyase. Mixtures of DNA probes coupled to CAL Fluor Red 590 (Stellaris, LGC Biosearch, Novato, CA; probes were synthesized by BioCat, Heidelberg, Germany) were used for smFISH, targeting the *FBA1, GFA1, PAT1, or PGK1* open reading frame moiety (Supplementary [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). Microscopy was performed with an inverted epi-fluorescence microscope (Nikon Ti) equipped with a Spectra X LED light source and a Hamamatsu Flash 4.0 sCMOS camera using a PlanApo 100 x NA 1.4 oil-immersion objective and the NIS Elements software. Images were processed using FIJI software. Quantification of colocalization was performed on all planes of a 3D stack image using the Colocalization Threshold tool in Fiji. In brief, images were background-subtracted and thresholded with a defined minimum threshold set for each smFISH probe separately. Then, the Colocalization Threshold tool was applied, which highlighted the colocalization between PB and mRNA. The colocalization events and the total number of PBs were then counted manually. The percentage of colocalization was calculated by forming the ratio between the number of PBs colocalizing with mRNA and the total number of PBs.

Immunoprecipitation {#s4-5}
-------------------

Immunoprecipitation experiments were performed as in ([@bib52]). Yeast were inoculated in synthetic media containing 2% glucose and grown overnight to saturation, then diluted the following day in 1 L synthetic media and grown to exponential growth phase (OD~600~ = 0.4--1.0). Cells were harvested by centrifugation at 3000 x *g* for 10 min, then resuspended in resuspension buffer (final concentration: 20 mM HEPES-KOH, pH 7.4, 1.2% polyvinylpyrrolidone (molecular weight = 40,000), 1 mM DTT, 0.2 mM PMSF, 10 μg/mL Pepstatin A). Pellets were centrifuged at 2600 x *g* for 15 min at 4°C to remove extra buffer, then centrifuged again at 2600 x *g* for 15 min at 4°C and pellets were frozen in liquid nitrogen and stored at −80**°**C. Frozen yeast pellets were then lysed with a Retsch Planetary Ball Mill MM 301 (Retsch, Newtown, PA) for six cycles at 30 Hz for 3 min with cooling in liquid nitrogen between cycles. 0.5 g of lysate was then resuspended in 14 mL TBT buffer (final concentration: 20 mM HEPES-KOH, pH 7.4, 110 mM KOAc, 2 mM MgCl~2~, 1 mM DTT, 0.5% Triton X-100, 0.1% Tween-20, 0.2 mM PMSF, 10 μg/mL Pepstatin A, 1:5000 SuperRNasin (Ambion, Austin, TX), 1:5000 Antifoam B (Sigma Aldrich, St. Louis, MO). Lysate was clarified through 2.7 µm and 1.6 µm GD/X Glass Microfiber syringe filters (Whatman, Maidstone, UK), and then incubated with 8 mg rabbit IgG (Sigma Aldrich)-coupled magnetic beads (Thermo Fischer, Waltham, MA) -- corresponding to 400 μL bead slurry at 20 mg/μL slurry -- and rotated at 4°C for 30 min. The beads were collected using a magnetic rack, washed three times with 1 mL TBT buffer, and a final wash in 1 mL of 100 mM NH~4~OAc, (pH = 7.4, 0.1 mM MgCl~2~, 0.2% Tween-20) for 5 min while rotating. Protein complexes were eluted from the beads directly in SDS-PAGE sample buffer and boiled at 95°C, and processed further for Western blot.

Western blot analysis {#s4-6}
---------------------

For Western blot analysis, roughly 5 OD~600~ units of cells were harvested and treated with 5% trichloroacetic acid (TCA) and incubated at 4°C for 10 min. Acid was removed using an acetone wash, and the resulting pellet was dried 2--3 hr. Cell pellets were resuspended in 200 μL breakage buffer (final concentration: 50 mM Tris-HCl pH = 7.5, 1 mM EDTA, 2.75 mM DTT, and protease inhibitors) and disrupted using glass beads and a Mini-Beadbeater-96 (BioSpec Products, Inc. Bartlesville, OK). Samples were cooled on ice for 5 min and SDS sample buffer was added and homogenates were boiled. Proteins were resolved by 4--12% Bolt Bis-Tris SDS PAGE (Thermo Fischer, Waltham, MA), then transferred to nitrocellulose membrane (GE Life Sciences, Marlborough, MA). Membranes were blocked in PBS with 4% non-fat milk, followed by incubation with primary antibody overnight. Membranes were washed four times with PBS with 0.1% Tween-20 (PBS-T) and incubated with secondary antibody for 45 min. Membranes were then analyzed and quantified using an infrared imaging system (Odyssey; LI-COR Biosciences, Lincoln, NE). The following primary antibodies were used for detection of tagged proteins at the indicated dilutions: rabbit-anti-Dhh1 (1:5000) as described in ([@bib22]), (Weis Lab ETH Zurich Cat\# Weis_001, RRID:[AB_2629458](https://scicrunch.org/resolver/AB_2629458)), anti-FLAG-M2 (1:2500) (Sigma-Aldrich Cat\# F1804, RRID:[AB_262044](https://scicrunch.org/resolver/AB_262044), St. Louis, MO), mouse-anti-HA.11 (1:2000) (Covance Research Products, Inc. Cat\# MMS-101P-1000, RRID:[AB_291259](https://scicrunch.org/resolver/AB_291259), Princeton, NJ) mouse-anti-GFP (1:1000) (Roche Cat\# 11814460001, RRID:[AB_390913](https://scicrunch.org/resolver/AB_390913)), and rabbit-anti-Hxk1 (1:3000) (US Biological Cat\# H2035-01, RRID:[AB_2629457](https://scicrunch.org/resolver/AB_2629457), Salem, MA). IRdye 680RD goat-anti-rabbit (LI-COR Biosciences Cat\# 926--68071, RRID:[AB_10956166](https://scicrunch.org/resolver/AB_10956166)) and IRdye 800 donkey-anti-mouse (LI-COR Biosciences Cat\# 926--32212, RRID:[AB_621847](https://scicrunch.org/resolver/AB_621847)) were used as secondary antibodies.

Wide-field fluorescence microscopy {#s4-7}
----------------------------------

Samples were grown overnight in synthetic media containing 2% glucose, diluted to OD~600~ = 0.05 or 0.1 the following day, and grown to mid-log phase (OD~600~= 0.3--0.8). Cells were harvested by centrifugation and washed in ¼ volume of fresh synthetic media +/− 2% glucose, then harvested again and resuspended in 1 volume of fresh synthetic media +/− 2% glucose and grown 15 min at 30°C. Cells were then transferred onto Concanavalin A-treated MatTek dishes (MatTek Corp., Ashland, MA) and visualized at room temperature using the DeltaVision Elite Imaging System with softWoRx imaging software (GE Life Sciences, Marlborough, MA). The system was based on an Olympus 1X71 inverted microscope (Olympus, Japan), and cells were observed using a UPlanSApo 100 × 1.4 NA oil immersion objective. Single plane images were acquired using a DV Elite CMOS camera. Image processing for PB analysis was performed using Diatrack 3.5 particle tracking software as described below.

Spinning disk confocal microscopy {#s4-8}
---------------------------------

Samples were grown as indicated in \'wide-field fluorescence microscopy\' methods section and imaged using an Andor/Nikon Yokogawa spinning disk confocal microscope (Belfast, United Kingdom) with Metamorph Microscopy Automation & Image Analysis software (Molecular Devices, Sunnyvale, CA). The system was based on a NikonTE2000 with inverted microscope, and cells were observed using a PlanApo100 × 1.4 NA oil immersion objective and single plane images were captured using a Clara Interline CCD camera (Andor).

Fluorescence recovery after photobleaching (FRAP) {#s4-9}
-------------------------------------------------

Samples were grown overnight in synthetic media containing 2% glucose, diluted to OD~600~ = 0.05 or 0.1 the following day, and grown to mid-log phase (OD~600~= 0.3--0.8). Cells were harvested by centrifugation and washed in ¼ volume of fresh synthetic media +/− 2% glucose, then harvested again and resuspended in 1 volume of fresh synthetic media +/− 2% glucose and grown 15 min at 30°C. Cells were then transferred onto Concanavalin A-treated MatTek dishes (MatTek Corp., Ashland, MA) and visualized at room temperature. Dhh1-GFP and Dhh1^DQAD^-GFP photobleaching experiments were performed on a Leica SP8 Laser Scanning Confocal Microscope (Leica, Wetzlar, Germany) using Leica LAS AF SP8 software (version 3.3). The system was based on a LeicaDMI6000B inverted microscope, and cells were observed using a PlanApo 63 × 1.4 NA oil immersion CS2 objective and a conventional photomultiplier tube (PMT) detector. Dcp1-GFP, Dcp2-GFP, Edc3-GFP, and Xrn1-GFP photobleaching experiments were performed on a Andor/Nikon Yokogawa spinning disk confocal microscope with acquisition parameters as described above.

Using the Leica SP8 Laser Scanning Confocal Microscope, selected PBs were subjected to 5--10 pulses of an argon laser at 488 nm. Images were collected from a single plane with a 2.92 nm pinhole at 500 ms intervals for 50 s post-bleach. Using the Andor/Nikon spinning disk confocal microscope, selected PBs were pulsed once for 500 ms using a Mosaic 405 nm laser (Andor) and images were collected from a single plane at 3 s intervals for 3 min post-bleach. For all experiments, PB fluorescent intensity and total cellular fluorescence intensity were quantified in ImageJ/FIJI by manual tracing. The background was determined by determining the intensity of an ROI with the same size as either the PB or the total cell. PB intensity was normalized to the total fluorescent intensity of the cell using the equation:$$PB_{normal} = \frac{Intensity_{PB} - Intensity_{PB\ background}}{Intensity_{TotalCell} - Intensity_{TotalCellBackground}}$$

Recovery curves were generated by normalization to the bleach point, and percent of fluorescent recovery values were determined by curve fitting using the equation:$$f(t) = A(1 - e^{- rt})$$

Automated image analysis for processing body quantification {#s4-10}
-----------------------------------------------------------

To quantify PBs, we used Diatrack 3.5 particle tracking software ([@bib71]; [www.diatrack.org](http://www.diatrack.org)). A Matlab script transformed our foci images into a single long sequence that could be fed to Diatrack. This allowed the same image analysis parameters to be applied across all images and experiments. PBs display significant variations in appearance (size and brightness). They were identified in Diatrack based on their intensity and contrast measure. Optimal parameters were selected interactively such that false negative and false positive rates were below 3%. Occasionally, yeast vacuoles pinch the cytoplasm against the cell wall. This tends to create narrow intensity ridges in some of our fluorescence images and can trigger the default Diatrack particle detector. Thus, we used an alternative contrast measure ('blurred 360'). This only retained particles around which the intensity decreases significantly in all directions (rather than decreasing on average only). A sample movie showing detected PB for a variety of images is provided as supplementary information (movieDetection.avi). For each image, a list of intensities corresponding to each PB in each image was exported from the software and further processed in Microsoft Excel (Microsoft Corporation, Redmond, WA). The sum of particle intensities represents a suitable measure of overall PB abundance. Alternately, the number of PBs per image may also be used. This value was divided by the number of cells in each image to deliver per-cell PB abundances. Automated counting of cells was performed as described in ([@bib31]).

Protein purification {#s4-11}
--------------------

Dhh1 (wild-type, Dhh1^DQAD^, Dhh1^F66R^) and Dbp5 were cloned into a pETMCN-based expression vector with a N-terminal 6xHis and V5 tag plus a C-terminal mCherry tag. The MIF4G domain of Not1 (residues 754--1000) was cloned into a pETMCN-based expression vector with a N-terminal 6xHis and V5 tag. Recombinant proteins were expressed in E. coli BL21 DE3 cells grown in rich medium. Cells were grown at 37°C to an OD~600~ of 0.6 and induced with 300 µM IPTG. Cells were then grown overnight at 18°C, harvested and resuspended in 30 mL lysis buffer (500 mM NaCl, 25 mM Tris-HCl pH 7.5, 10 mM imidazole, protease inhibitors) per cell pellet from 2 L of culture. After cell lysis by sonication, the 6xHis tagged proteins were affinity extracted with Ni^2+^ sepharose and further purified by size exclusion with a Superdex 200 column (Dhh1 and Dbp5, in the final storage buffer 200 mM NaCl, 25 mM Tris-HCl pH 7.5, 2 mM DTT) or Superdex 75 column (Not1^MIF4G^, in the final storage buffer 200 mM NaCl, 25 mM Tris-HCl pH 7.5, 2 mM DTT, 10% glycerol) (GE Life Sciences, Marlborough, MA). Gel filtration fractions were analyzed by SDS-PAGE. Clean fractions were pooled, concentrated to about 500 µM and snap frozen in small aliquots.

ATPase assay {#s4-12}
------------

ATPase assays were performed according to ([@bib48]) with the following modifications: 2 µM Dhh1 or Dbp5 was mixed with 2 µL 10x ATPase buffer (300 mM HEPES-KOH pH 7.5, 1 M NaCl, 20 mM MgCl~2~), Not1 or Gle1 as indicated, 4 µL 10 mg/ml polyU (unless indicated otherwise), RNase inhibitors, 13.3 µL 60% glycerol, 2.7 µL 10 mg/mL BSA, and Not1 storage buffer to compensate for volume differences, in a final volume of 36 µL. Reactions were set up in triplicate in a 96-well NUNC plate. The assay was initiated by the addition of 40 µL of a master mix containing 1x ATPase buffer, 2.5 mM ATP (from a 100 mM stock in 0.5 M HEPES-KOH pH 7.5), 1 mM DTT, 6 mM phosphoenolpyruvate, 1.2 mM NADH (from a 12 mM stock in 25 mM HEPES-KOH pH 7.5) and 125--250 units / mL PK/LDH. NADH absorption was monitored with a CLARIOstar plate reader at 340 nm in 30 s intervals for 400 cycles.

*in vitro* liquid droplet reconstitution assay {#s4-13}
----------------------------------------------

Dhh1-mCherry (wild-type, Dhh1^DQAD^, or Dhh1^F66R^) was diluted at least tenfold to 50 µM with 1x ATPase buffer. From this solution, Dhh1 was added as indicated in [Figure 6](#fig6){ref-type="fig"} to a 20 µL reaction (and pre-incubated with Not1, if applicable) in a 384-well microscopy plate. Reactions were filled to 5 µL with 1x ATPase buffer. A master mix was prepared with 2 µL 10x ATP reconstitution system (40 mM ATP, 40 mM MgCl~2~, 200 mM creatine phosphate, 70 U/mL Creatine Kinase), 1 µL HEPES-KOH pH 6.6, 1 µL BSA (10 mg/mL), 1.5 µL 1 mg/mL polyU (unless indicated otherwise), 0.2 µL RNase inhibitors and 10 µL buffer (150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM MgCl~2~) and added to the protein solutions. For the reactions not containing the creatine kinase ATP regeneration system, ATP was supplemented to a final concentration of 5 mM together with 10 mM MgCl~2~. Reactions were mixed, incubated at 4°C for the indicated length, and microscopy was performed with an inverted epi-fluorescence microscope (Nikon Ti) equipped with a Spectra X LED light source and a Hamamatsu Flash 4.0 sCMOS camera using a PlanApo 60 × NA 1.4 oil-immersion objective and the NIS Elements software.
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Thank you for submitting your article \"ATPase activity of the DEAD-box protein Dhh1 controls processing body formation\" for consideration by *eLife*. Your article has been favorably evaluated by James Manley (Senior Editor) and three reviewers, one of whom, Alan G Hinnebusch (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor, Alan Hinnebusch, has drafted this decision to help you prepare a revised submission.

Summary of work:

This paper shows that the ATPase activity of Dhh1, and its regulator Not1, modulate P body formation in yeast, as a Dhh1 mutation impairing ATP hydrolysis by Dhh1 evokes constitutive P body formation in a manner dependent on mRNA binding by the mutant Dhh1. This leads to the proposal that trapping the mutant Dhh1-ATP on mRNA is the condition that evokes P body accumulation. In the course of this work, it is shown that Not1 binds to Dhh1 and activates its ATPase activity, extending previous findings on the mammalian orthologs CNOT and Ddx6, and then shown that deleting Not1 partially mimics the Dhh1 ATPase mutant in stimulating P body formation, consistent with their model. Evidence is also provided that aggregation of Dhh1-ATP/RNA complexes can be observed *in vitro* by the formation of liquid droplets that require ATP and RNA and can be dissolved by Not1. These results are potentially interesting in providing a first step in the reconstitution of P body formation *in vitro* by Dhh1-ATP-mRNA complexes.

Essential revisions required:

*Reviewer \#1:*

Additional controls are required for the liquid droplet assay, including showing that the ATPase Dhh1 mutant would be active, while the ATP-binding Dhh1 mutant would be inactive in this assay, and that adding the Not1 fragment would have no effect on droplet formation if the ATPase Dhh1 mutant was employed, or with non-hydrolyzable ATP and WT Dhh1.

*Reviewer \#2:*

1\) A demonstration that P-body formation is impaired by the deletion of *DHH1* is required. Alternatively, authors should explain why *DHH1* deletion does not impact P-body formation in their model.

2\) If useful, the authors could extend their analysis in [Figure 2](#fig2){ref-type="fig"} of the Q-motif or RNA-binding mutants of Dhh1 to show that Dcp1-GFP and Edc3-GFP foci, as well as Dhh1-GFP foci, are reduced in these mutants on glucose starvation.

3\) Quantification of data for all 3 time points and adding a 10 min time point for the experiment in [Figure 3B](#fig3){ref-type="fig"} is required.

4\) For the experiment in [Figure 4B](#fig4){ref-type="fig"}, an untagged Dhh1 strain needs to be examined in parallel to determine the background level of non-specific Not1 coimmunoprecipitation.

5\) For the experiment in [Figure 6B](#fig6){ref-type="fig"}, determine whether the ATP-regenerating system is required for liquid droplet formation.

*Reviewer \#3:*

1\) Provide additional data to substantiate the claim that the dhh1-^DQAD^ mutation increases mRNA abundance, or mRNA co-localization with P-bodies only marginally compared what occurs in an xrn1 mutant; or dampen the interpretations of the existing experiments and provide additional arguments that mRNA accumulation is unlikely to play a major role in the elevated P body assembly of the dhh1-^DQAD^ mutant.

2\) Better substantiate the effects of the Dhh1 and Not1 mutations that impair complex formation between the two proteins in the induction of P bodies in non-starvation conditions as follows: Provide more convincing data showing accumulation of Dhh1-GFP foci in +glucose conditions in [Figures 4C](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"} for the dhh1-5X-Not and not1-5x-Dhh1 mutants. Provide quantification of Dcp1-GFP and/or Edc3-GFP foci in +Glucose conditions for these two mutants in the experiments of Figure.4---figure supplement 1D and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}).

Reviewer comments below.

*Reviewer \#1:*

This paper shows that the ATPase activity of Dhh1, and its regulator Not1, modulate P body formation in yeast, as a Dhh1 mutation impairing ATP hydrolysis by Dhh1 evokes constitutive P body formation in a manner dependent on mRNA binding by the mutant Dhh1. This allows them to propose that trapping the mutant Dhh1-ATP on mRNA is the condition that evokes P body accumulation. In the course of this work, they show that Not1 binds to Dhh1 and activates its ATPase activity, extending previous findings on the mammalian orthologs CNOT and Ddx6, and then show that deleting Not1 partially mimics the Dhh1 ATPase mutant in stimulating P body formation, consistent with their model. They also provide evidence that aggregation of Dhh1-ATP/RNA complexes can be observed *in vitro* by the formation of liquid droplets that require ATP and RNA and can be dissolved by Not1. Additional controls are likely required for this assay, but the results are potentially interesting as a first step in the reconstitution of P body formation by Dhh1-ATP-mRNA complexes.

They begin first by extending their previous findings and show that the cytoplasmic granules formed in yeast cells on expressing the ATPase deficient Dhh1 are *bona fide* processing (P) bodies, whose formation requires RNA binding by the ATPase mutant Dhh1; whereas P body formation is not induced by a Dhh1 mutant that fails to bind ATP, and P bodies do not form in this mutant nor with the RNA-binding defective version of Dhh1 under glucose starvation conditions. Thus, it appears that constitutive mRNA binding by Dhh1-ATP appears to evoke P bodies. They showed previously by FRAP that the ATPase mutant doesn\'t shuttle in and out of P-bodies and they show that the P bodies formed by this mutant also disassemble more slowly on cycloheximide treatment, although the interpretation of this result isn\'t stated. (Does it result from prolonged retention in P bodies of mRNAs bound to Dhh1-ATP?). Biochemical experiments show that, analogous to previous findings that mammalian CNOT stimulates the ATPase activity of mammalian Dhh1 (Ddx6), yeast Not1 stimulates the ATPase activity of yeast Dhh1 *in vitro* using recombinant proteins for the experiments. They identified a Dhh1 mutant that binds Not1 poorly compared to WT Dhh1, and showed that it mimics the ATPase mutant of Dhh1 in provoking P body formation that requires the RNA-binding activity of the mutant Dhh1, as expected if Not1 is required for ATP hydrolysis by Dhh1 and Dhh1-ATP is the trigger for P body formation. They attempted to prove that the Dhh1 mutant that impairs Not1 association evokes PBs only because of its reduced Not1 interaction by examining a Not1 variant lacking residues thought to be required for Dhh1 binding. It too induces PBs but to a much smaller extent than do the Dhh1 mutants; so they can\'t completely eliminate the possibility that the Dhh1 variant induces P bodies strictly owing to defective binding to Not1 and attendant reduction in ATPase activity. Note however that they would have to verify that these Not1 mutations actually do impair its binding to Dhh1. Finally, they show that *in vitro* Dhh1 can form liquid droplets that form in a concentration dependent fashion in a manner absolutely dependent on RNA (poly(U)) and ATP, and reversed by addition of the presumed Dhh1 interacting-domain of Not1. They propose that this represents an *in vitro* analogue of PB assembly, wherein Dhh1-ATP would multimerize on mRNA to nucleate P body formation. Additional controls seem to be required, such as showing that the ATPase Dhh1 mutant would be active, while the ATP-binding Dhh1 mutant would be inactive in this assay, and that Not1 would have no effect on droplet formation if the ATPase Dhh1 mutant was employed, or with non-hydrolyzable ATP and WT Dhh1.

1\) It is important to verify that the Not1 mutations presumed to impair its binding to Dhh1 actually do so.

2\) Additional controls are required for the liquid droplet assay, including a demonstration that the ATPase Dhh1 mutant is active, while the ATP-binding Dhh1 mutant is inactive in this assay, and that Not1 has no effect on droplet formation if the ATPase Dhh1 mutant is employed, or when using non-hydrolyzable ATP and WT Dhh1.

*Reviewer \#2:*

In this manuscript, the group of Karsten Weis proposes that the *DHH1* protein is, through its ATPase activity, a major regulator of P-body formation. The manuscript addresses an interesting question. Several points are, however, questionable:

1\) Most importantly, the authors fail to mention that previous work as demonstrated normal (or nearly normal) P-body formation in a yeast strain lacking *DHH1* (Teixeira and Parker, 2007). It is difficult to reconcile this observation with the model presented in the current manuscript. The authors should minimally quote the literature, test whether the original observation is reproducible and, if so, whether the kinetics of P-body formation and/or disappearance are altered in the absence of *DHH1*. This issue should also be discussed.

2\) The assay for the kinetic of disappearance of P-body in strains expression with-type or ATPase-deficient *DHH1* is not particularly convincing: Is a 4 dots versus 0 dot distribution significantly different from 2 dots versus 2 dots ([Figure 3](#fig3){ref-type="fig"}, 20 min)? Is the situation identical in both cases at time 0? Can one conclude at a significant kinetic difference with two time points? This assay would be improved with additional time points and a more quantitative analysis of the data.

3\) In [Figure 4B](#fig4){ref-type="fig"}, there is no control for the specificity and background signal in immunoprecipitation. This is not satisfactory given the state of the art for such experiments. This is unlikely to meet the standard for publication in *eLife*.

4\) The analysis of the formation of liquid droplets is incomplete with respect to the other parts of the manuscript. Indeed, the authors argue that they recapitulate P-body dynamics *in vitro*. They could have easily checked that non-hydrolizable ATP analog promote liquid droplet formation and that in this context addition of NOT1-MIF4G does not dissolve the droplets to support this conclusion. In [Figure 6B](#fig6){ref-type="fig"}, they do not even show whether ATP recycling is necessary to support liquid droplet formation (sample minus \"creatine kinase regeneration system\" that should probably be re-labeled \"ATP regeneration system\"). If ATP recycling is necessary, this would contradict the observation made with the ATPase-dead *DHH1* and the results showing that the NOT1-MIF4G is required to stimulate *DHH1* activity.

Altogether, while this manuscript addresses an interesting question, its main conclusion is difficult to reconcile with some data reported in the literature and this point is not adequately addressed. Moreover, some experiments remain preliminary or insufficiently controlled. Significant revision of the manuscript is necessary before a possible publication in *eLife*.

*Reviewer \#3:*

In this work Mugler et al. study the Dhh1 protein and its role, and the role of ATP binding and hydrolysis, in formation and disassembly of P bodies.

From all of their data the authors propose a model in which ATP-bound Dhh1 with RNA and additional factors contribute to formation of p bodies that are dynamic and disassemble upon ATP hydrolysis with the help of Not1 interaction.

Altogether this is a nice study and my opinion is that it provides new findings of broad interest and it is worth publishing.

However, I also feel that there is data in the manuscript that would need to be improved and interpretations that maybe should be revisited. I will describe my specific comments on the experiments below.

The authors show that expression of a mutant Dhh1 that is unable to hydrolyze bound ATP leads to the formation of granules in which it and other P body components localize in the absence of stress.

The mutant Dhh1 is still able to induce decay of an mRNA to which it is tethered. The authors argue that hence the formed p bodies are not due to an accumulation of undegraded mRNAs. They confirm this interpretation of this data by looking at the co-localization of FBA1 and GFA1 mRNA with the sites of mutant Dhh1 accumulation, and determine that it is not as significant as in the localization of these mRNAs in p bodies appearing in strains lacking Xrn1.

I am not very convinced by this argument and experiment. It is in my mind the weakest of the paper. Degradation of mRNAs by tethering is a very artificial situation and I have my doubts that it pheno-copies all aspects of mRNA degradation *in vivo.*

The use of the tethering experiment is very artificial (and I know that the field uses this extensively) and in my mind it has the same type of caveats as the original fusions used to demonstrate transcriptional activation by tethering proteins to promoters.

We fail to understand the impact of the mutant Dhh1 on total levels of the tested mRNAs and on total mRNA levels, that might contribute to p body formation. The immunofluorescence is not clear.

I would argue that either the authors need to improve data (more complete data about the mutant effect on mRNA levels globally and the single molecule FISH) or their claim about the role of altered RNA degradation should be dampened.

The authors also show that the lack of interaction of Dhh1 with Not1, leads to p body formation even in glucose in which Dcp2 is visible. The authors conclude that the mutant Dhh1 itself localizes to these p bodies and that this needs RNA binding of Dhh1. This data is not very easy to see and not very convincing ([Figure 4C](#fig4){ref-type="fig"}). The authors also show that this mutant is still capable of repressing mRNA in their tethering assay. The authors also make a Not1 mutant that does not interact with Dhh1 and conclude that the effect is the same, but maybe a little milder. Here also, while I agree that other components can be seen in p bodies in glucose, the localization of Dhh1 in these foci is not convincing.

10.7554/eLife.18746.030

Author response

*Essential revisions required:*

*Reviewer \#1:*

*Additional controls are required for the liquid droplet assay, including showing that the ATPase Dhh1 mutant would be active, while the ATP-binding Dhh1 mutant would be inactive in this assay, and that adding the Not1 fragment would have no effect on droplet formation if the ATPase Dhh1 mutant was employed, or with non-hydrolyzable ATP and WT Dhh1.*

As requested we have extended our analysis of Dhh1 liquid droplet formation *in vitro* using additional mutants of Dhh1 in [Figure 6](#fig6){ref-type="fig"}. As expected from our previous results, the ATPase-dead Dhh1~DQAD~ variant forms droplets *in vitro* that cannot be dissolved by the addition of Not1~MIF4G~. We also have added new results demonstrating that the presence of ATP is essential for droplet formation *in vitro* ([Figure 6B](#fig6){ref-type="fig"}). With respect to the importance of Dhh1 ATP binding in liquid droplet formation, despite numerous attempts we were unable to purify the Dhh1~Q-motif~ mutant (F66R/Q73A) with sufficiently high quality from *E. coli* to assess whether this mutant showed a defect in liquid droplet formation. However, we successfully purified a single Dhh1~F66R~ point mutant in the Q-motif of Dhh1 (Dutta et. al 2011). While this mutant shows only a mild defect in PB formation *in vivo*([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}), Dhh1~F66R~ has a strong defect in liquid droplet formation *in vitro* ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), suggesting that robust ATP binding by Dhh1 is required for liquid droplet formation.

*Reviewer \#2:*

*1) A demonstration that P-body formation is impaired by the deletion of DHH1 is required. Alternatively, authors should explain why DHH1 deletion does not impact P-body formation in their model.*

We apologize that this important issue was not sufficiently discussed, and we have modified the text to highlight a prior publication from the Parker lab (Teixeira and Parker 2007), which suggested that PB formation is not strongly affected in *dhh1∆* cells. Importantly, we now also include a careful quantification of PB formation (using Dcp2-mCherry as a marker) in both *DHH1* and *dhh1∆* cells demonstrating that Dhh1 is indeed critical for PB formation ([Figure 2B](#fig2){ref-type="fig"}). In contrast to the data from Teixeira et al. showing only representative images, our imaging platform allowed us to quantify \>1000 cells per experiment. This analysis demonstrates that *dhh1∆* cells have a severe defect in PB formation and show a roughly 80% reduction in Dcp2-mCherry positive foci formation upon glucose starvation.

2\) If useful, the authors could extend their analysis in [Figure 2](#fig2){ref-type="fig"} of the Q-motif or RNA-binding mutants of Dhh1 to show that Dcp1-GFP and Edc3-GFP foci, as well as Dhh1-GFP foci, are reduced in these mutants on glucose starvation.

We have bolstered our quantification of PB localization in Q-motif and RNA-binding mutants of Dhh1 by including PB localization data for each of these mutants co- expressing Dcp2-mCherry, as well as Xrn1-GFP, Dcp1-GFP, Edc3-GFP, in [Figure 2](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A--C](#fig2s1){ref-type="fig"}.In addition, we have included confocal microscopy images of the defects in PB localization for all decay factors examined in *dhh1~Q-motif~*and *dhh1~3X-RNA~*strains in [Figure 2](#fig2){ref-type="fig"}and [Figure 2---figure supplement 1A- C](#fig2s1){ref-type="fig"}.

3\) Quantification of data for all 3 time points and adding a 10 min time point for the experiment in [Figure 3B](#fig3){ref-type="fig"} is required.

As requested, we have modified the experiment in [Figure 3B](#fig3){ref-type="fig"}to now include time points of 0, 10, 20, 40, 60 and 120 min post-cycloheximide treatment. We have also quantified the percentage of PBs present in each condition to highlight the difference in PB disappearance between wild-type and Dhh1~DQAD~ PBs. In addition to the updated images in [Figure 3B](#fig3){ref-type="fig"}, we have also included [Video 1](#media1){ref-type="other"}and [Video 3](#media3){ref-type="other"}, showing wild-type Dhh1-GFP and Dhh1DQAD-GFP PB disassembly, respectively, along with [Videos 2](#media2){ref-type="other"} and [4](#media4){ref-type="other"}showing that DMSO treatment alone does not cause disassembly in these cells. Together, this firmly demonstrates that the disassembly kinetics of Dhh1~DQAD~ PBs following cycloheximide treatment are slower than that of wild-type PBs. Because the images in [Figure 3B](#fig3){ref-type="fig"}now only show Dhh1-GFP fluorescence, we have also added images showing disappearance of Dcp2-mCherry foci in Dhh1 and Dhh1~DQAD~-expressing cells in [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}.

4\) For the experiment in [Figure 4B](#fig4){ref-type="fig"}, an untagged Dhh1 strain needs to be examined in parallel to determine the background level of non-specific Not1 coimmunoprecipitation.

This important control has been added to [Figure 4B](#fig4){ref-type="fig"}, and confirms that Not1 is not precipitated in the absence of a TAP-tagged copy of Dhh1.

5\) For the experiment in [Figure 6B](#fig6){ref-type="fig"}, determine whether the ATP-regenerating system is required for liquid droplet formation.

We have included the requested experiment in [Figure 6B](#fig6){ref-type="fig"}, which demonstrates that addition of ATP in the absence of the ATP regeneration system is sufficient to induce droplet formation. For consistency reasons, this is presented as a separate panel, since other experiments with mutants etc. were performed in the presence of both ATP and the ATP regeneration system.

*Reviewer \#3:*

*1) Provide additional data to substantiate the claim that the dhh1-^DQAD^ mutation increases mRNA abundance, or mRNA co-localization with P-bodies only marginally compared what occurs in an xrn1 mutant; or dampen the interpretations of the existing experiments and provide additional arguments that mRNA accumulation is unlikely to play a major role in the elevated P body assembly of the dhh1-^DQAD^ mutant.*

We thank the reviewer for this comment and have altered the text and added new experiments to address these issues. Indeed, we and others have previously shown that expression of *dhh1~DQAD~*causes stabilization/increased levels of certain mRNAs (Carroll et al., 2011; Dutta et al., 2011), suggesting that RNA decay of these transcripts is affected by loss of Dhh1 ATPase activity. Our conclusion from the data presented in [Figure 1](#fig1){ref-type="fig"} is that mRNAs can be degraded in 'normal' PBs as well as in Dhh1~DQAD~--induced PBs, and that PB formation in Dhh1~DQAD~ cells is not solely due to a block in mRNA decay within the PB. We have altered our text to more accurately reflect this point. As requested by the reviewer, we have also added additional smFISH data for two more transcripts -- *PAT1* and *PGK1* ([Figure 1---figure supplement 1B--C](#fig1s1){ref-type="fig"}), further demonstrating that mRNAs accumulate in PBs of Dhh1~DQAD~ cells to a lower level than in PBs of *xrn1∆* cells. Furthermore, we have added new images for the *FBA1* transcript in [Figure 1](#fig1){ref-type="fig"} to better illustrate the difference in mRNA localization between *xrn1∆* and *dhh1~DQAD~*cells.

However, we agree that it is likely that the kinetics of mRNA decay in Dhh1~DQAD~-- expressing cells are reduced compared to wild-type cells, and this slower decay probably contributes to the presence of PBs in *dhh1~DQAD~*cells in the absence of stress. This observation is also supported by the slower recycling of Dhh1~DQAD~ from PBs in FRAP experiments ([Figure 3A](#fig3){ref-type="fig"}), and the slower dissolution of Dhh1~DQAD~ PBs upon cycloheximide treatment ([Figure 3B](#fig3){ref-type="fig"}). Currently, there are no Dhh1 mutants that would allow the uncoupling of the effects of Dhh1 on mRNA turnover and PB formation (and it is likely that such mutants may not exist) and we have therefore altered the text to more carefully discuss the role of Dhh1 in decay and PB formation.

2\) Better substantiate the effects of the Dhh1 and Not1 mutations that impair complex formation between the two proteins in the induction of P bodies in non-starvation conditions as follows: Provide more convincing data showing accumulation of Dhh1-GFP foci in +glucose conditions in [Figures 4C](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"} for the dhh1-5X-Not and not1-5x-Dhh1 mutants. Provide quantification of Dcp1-GFP and/or Edc3-GFP foci in +Glucose conditions for these two mutants in the experiments of [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"} and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}).

We have addressed all these points and have performed confocal microscopy to better visualize the differences in PB formation between cells expressing Dhh1~5X-Not~ and wild-type Dhh1 in glucose-rich conditions in [Figure 4C](#fig4){ref-type="fig"}, and in cells expressing Not1 and Not1~9X-Dhh1~ in [Figure 5](#fig5){ref-type="fig"}. We have also performed quantification of Dcp2- mCherry in these conditions for [Figures 4](#fig4){ref-type="fig"}and [5](#fig5){ref-type="fig"}, as well as Xrn1-GFP, Dcp1-GFP, and Edc3-GFP for [Figure 4---figure supplement 1D--F](#fig4s1){ref-type="fig"} and [Figure 5---figure supplement 1A--C](#fig5s1){ref-type="fig"}.

*Reviewer comments below.*

*Reviewer \#1:*

*This paper shows that the ATPase activity of Dhh1, and its regulator Not1, modulate P body formation in yeast, as a Dhh1 mutation impairing ATP hydrolysis by Dhh1 evokes constitutive P body formation in a manner dependent on mRNA binding by the mutant Dhh1. This allows them to propose that trapping the mutant Dhh1-ATP on mRNA is the condition that evokes P body accumulation. In the course of this work, they show that Not1 binds to Dhh1 and activates its ATPase activity, extending previous findings on the mammalian orthologs CNOT and Ddx6, and then show that deleting Not1 partially mimics the Dhh1 ATPase mutant in stimulating P body formation, consistent with their model. They also provide evidence that aggregation of Dhh1-ATP/RNA complexes can be observed in vitro by the formation of liquid droplets that require ATP and RNA and can be dissolved by Not1. Additional controls are likely required for this assay, but the results are potentially interesting as a first step in the reconstitution of P body formation by Dhh1-ATP-mRNA complexes.*

We thank this reviewer for this positive assessment and as discussed above we have added the requested controls.

*They begin first by extending their previous findings and show that the cytoplasmic granules formed in yeast cells on expressing the ATPase deficient Dhh1 are bona fide processing (P) bodies, whose formation requires RNA binding by the ATPase mutant Dhh1; whereas P body formation is not induced by a Dhh1 mutant that fails to bind ATP, and P bodies do not form in this mutant nor with the RNA-binding defective version of Dhh1 under glucose starvation conditions. Thus, it appears that constitutive mRNA binding by Dhh1-ATP appears to evoke P bodies. They showed previously by FRAP that the ATPase mutant doesn\'t shuttle in and out of P-bodies and they show that the P bodies formed by this mutant also disassemble more slowly on cycloheximide treatment, although the interpretation of this result isn\'t stated. (Does it result from prolonged retention in P bodies of mRNAs bound to Dhh1-ATP?). Biochemical experiments show that, analogous to previous findings that mammalian CNOT stimulates the ATPase activity of mammalian Dhh1 (Ddx6), yeast Not1 stimulates the ATPase activity of yeast Dhh1 in vitro using recombinant proteins for the experiments. They identified a Dhh1 mutant that binds Not1 poorly compared to WT Dhh1, and showed that it mimics the ATPase mutant of Dhh1 in provoking P body formation that requires the RNA-binding activity of the mutant Dhh1, as expected if Not1 is required for ATP hydrolysis by Dhh1 and Dhh1-ATP is the trigger for P body formation. They attempted to prove that the Dhh1 mutant that impairs Not1 association evokes PBs only because of its reduced Not1 interaction by examining a Not1 variant lacking residues thought to be required for Dhh1 binding. It too induces PBs but to a much smaller extent than do the Dhh1 mutants; so they can\'t completely eliminate the possibility that the Dhh1 variant induces P bodies strictly owing to defective binding to Not1 and attendant reduction in ATPase activity. Note however that they would have to verify that these Not1 mutations actually do impair its binding to Dhh1. Finally, they show that in vitro Dhh1 can form liquid droplets that form in a concentration dependent fashion in a manner absolutely dependent on RNA (poly(U)) and ATP, and reversed by addition of the presumed Dhh1 interacting-domain of Not1. They propose that this represents an in vitro analogue of PB assembly, wherein Dhh1-ATP would multimerize on mRNA to nucleate P body formation. Additional controls seem to be required, such as showing that the ATPase Dhh1 mutant would be active, while the ATP-binding Dhh1 mutant would be inactive in this assay, and that Not1 would have no effect on droplet formation if the ATPase Dhh1 mutant was employed, or with non-hydrolyzable ATP and WT Dhh1.*

As discussed above, the requested experiments are now included in the new [Figure 6](#fig6){ref-type="fig"}.

*1) It is important to verify that the Not1 mutations presumed to impair its binding to Dhh1 actually do so.*

We performed immunoprecipitation experiments of TAP-tagged Not1 and Not1~9X-\ Dhh1~ in order to assess whether mutation of conserved residues in Not1 showed defects in Dhh1 binding. However, while we consistently saw more Dhh1 precipitated by wild-type Not1-TAP compared with Not1~9X-Dhh1~-TAP or untagged Not1, these pull-downs were very inefficient and we were unable to precipitate enough Dhh1 with either Not1 or Not1~9X-Dhh1~-TAP to determine whether the differences in binding were significant. Therefore, we did not include this experiment in the manuscript.

*2) Additional controls are required for the liquid droplet assay, including a demonstration that the ATPase Dhh1 mutant is active, while the ATP-binding Dhh1 mutant is inactive in this assay, and that Not1 has no effect on droplet formation if the ATPase Dhh1 mutant is employed, or when using non-hydrolyzable ATP and WT Dhh1.*

We have performed the requested experiments, which are described in more detail above.

*Reviewer \#2:*

*In this manuscript, the group of Karsten Weis proposes that the DHH1 protein is, through its ATPase activity, a major regulator of P-body formation. The manuscript addresses an interesting question. Several points are, however, questionable:*

*1) Most importantly, the authors fail to mention that previous work as demonstrated normal (or nearly normal) P-body formation in a yeast strain lacking DHH1 (Teixeira and Parker, 2007). It is difficult to reconcile this observation with the model presented in the current manuscript. The authors should minimally quote the literature, test whether the original observation is reproducible and, if so, whether the kinetics of P-body formation and/or disappearance are altered in the absence of DHH1. This issue should also be discussed.*

As discussed above, we now include data demonstrating that PB formation is significantly affected in strains lacking *DHH1* and in *dhh1* mutants that cannot bind RNA.

2\) The assay for the kinetic of disappearance of P-body in strains expression with-type or ATPase-deficient DHH1 is not particularly convincing: Is a 4 dots versus 0 dot distribution significantly different from 2 dots versus 2 dots ([Figure 3](#fig3){ref-type="fig"}, 20 min)? Is the situation identical in both cases at time 0? Can one conclude at a significant kinetic difference with two time points? This assay would be improved with additional time points and a more quantitative analysis of the data.

As requested and discussed above, we have added additional time points and quantified the results.

3\) In [Figure 4B](#fig4){ref-type="fig"}, there is no control for the specificity and background signal in immunoprecipitation. This is not satisfactory given the state of the art for such experiments. This is unlikely to meet the standard for publication in eLife.

We have added this important control as described above.

*4) The analysis of the formation of liquid droplets is incomplete with respect to the other parts of the manuscript. Indeed, the authors argue that they recapitulate P-body dynamics in vitro*. *They could have easily checked that non-hydrolizable ATP analog promote liquid droplet formation and that in this context addition of NOT1-MIF4G does not dissolve the droplets to support this conclusion. In [Figure 6B](#fig6){ref-type="fig"}, they do not even show whether ATP recycling is necessary to support liquid droplet formation (sample minus \"creatine kinase regeneration system\" that should probably be re-labeled \"ATP regeneration system\"). If ATP recycling is necessary, this would contradict the observation made with the ATPase-dead DHH1 and the results showing that the NOT1-MIF4G is required to stimulate DHH1 activity.*

As described above we have now included the requested experiments confirming our previous conclusions on the role of ATP binding and hydrolysis by Dhh1 on droplet formation.

*Altogether, while this manuscript addresses an interesting question, its main conclusion is difficult to reconcile with some data reported in the literature and this point is not adequately addressed. Moreover, some experiments remain preliminary or insufficiently controlled. Significant revision of the manuscript is necessary before a possible publication in eLife.*

We have addressed the concern about the contribution of Dhh1 to PB formation *in vivo* and have improved all the criticized experiments. We feel that this has strengthened our previous conclusions.

*Reviewer \#3:*

*In this work Mugler et al. study the Dhh1 protein and its role, and the role of ATP binding and hydrolysis, in formation and disassembly of P bodies.*

\[...\]

*I would argue that either the authors need to improve data (more complete data about the mutant effect on mRNA levels globally and the single molecule FISH) or their claim about the role of altered RNA degradation should be dampened.*

As discussed above, we agree that it is -- to our knowledge -- not possible to uncouple the role of Dhh1 on decay and PB formation. We have modified the text in order to provide a more balanced discussion of our results. In addition, we have also included additional smFISH experiments to demonstrate that PB formation in the *dhh1~DQAD~*mutant is not simply due to a severe block of mRNA decay (as for example observed in *xrn1*∆ cells).

The authors also show that the lack of interaction of Dhh1 with Not1, leads to p body formation even in glucose in which Dcp2 is visible. The authors conclude that the mutant Dhh1 itself localizes to these p bodies and that this needs RNA binding of Dhh1. This data is not very easy to see and not very convincing ([Figure 4C](#fig4){ref-type="fig"}). The authors also show that this mutant is still capable of repressing mRNA in their tethering assay. The authors also make a Not1 mutant that does not interact with Dhh1 and conclude that the effect is the same, but maybe a little milder. Here also, while I agree that other components can be seen in p bodies in glucose, the localization of Dhh1 in these foci is not convincing.

As discussed above, we have added new confocal images that helped us to improve the quality of the data.

[^1]: These authors contributed equally to this work.
